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Abstract 
The manufacture, use and storage of explosives over decades have seriously 
contaminated the environment. Hexa-hydro-1,3,5-trinitro-1,3,5-triazine (Royal 
Demolition Explosive - RDX) is one of the most widely used explosives. RDX is a man-
made compound, recalcitrant to degradation and proven to be toxic to organisms. 
Bacteria capable of utilising RDX as a sole nitrogen source for growth have been 
isolated from RDX polluted sites including Rhodococcus rhodochrous 11Y. The RDX 
degrading genes, xplA and xplB encoding a novel flavodoxin fused cytochrome P450 
and its reductase partner respectively, were first identified in R. rhodochrous 11Y. This 
unusual P450 system has now been found in almost all of the RDX degrading bacteria 
isolated so far. To date, XplA/B remains the only characterised RDX degrading P450 
system and is encoded on an operon in strain 11Y, which also contains a putative 
permease (transporter) and transcriptional regulator. This gene cluster is highly 
conserved amongst other RDX degrading bacteria from geographically distinct regions 
including the United Kingdom, Belgium, Australia and North America, suggesting the 
xplA/B gene cluster may have been rapidly distributed across the globe by horizontal 
gene transfer. 
The first aim of this study was to characterise Rhodococcus erythropolis HS4, a 
bacterium that degrades RDX slowly but did not contain xplA and xplB. A number of 
approaches have been employed to characterise this strain, which includes whole cell 
assays, western analysis, cell free extract activity assays, PCR amplification and 
affinity purification of protein in R. erythropolis HS4. While whole cells of HS4 showed 
low RDX degrading activity, no RDX activity was observed in HS4 cell free extracts. 
Attempts to purify an RDX degrading enzyme from R. erythropolis HS4 were 
unsuccessful.  
The second aim of this project was to characterise the RDX degrading gene cluster in 
R. rhodochrous 11Y. Four genes encoding xplB, xplA, a putative permease and a 
MarR type regulator, were individually deleted using an unmarked gene deletion 
system (pK18mobsacB). The xplB knockout strain metabolised RDX more slowly than 
the wild-type suggesting XplA was able to obtain reducing equivalents from another 
source in the xplB knockout strain. The xplA knockout strain did not show RDX activity 
in whole cell and growth experiments. Neither xplA nor its gene product XplA was 
 3 
detected in the xplA knockout strain. The findings suggested no alternative RDX 
degrading system is present in strain 11Y. The permease knockout did not show 
significant difference in the RDX removal rate compared to wild-type. Another attempt 
to characterise the permease in 11Y was to express it in E. coli. No significant 
difference of RDX uptake between the permease-expressing clone and the control 
(non-expressing clone) in the uptake assays. The regulator knockout strain had a lower 
RDX degradation rate than wild-type in the presence of nitrate/nitrite. Also, when the 
regulator knockout and wild-type strains were previously exposed to nitrate/nitrite, the 
knockout showed lower RDX degrading activity. Further investigation of xplA regulation 
in strain 11Y showed that XplA activity was induced by nitrogen-limiting conditions and 
further induced by RDX. This was the first observation on the XplA activity could be 
induced by low nitrogen availability in medium. These results suggested that the 
regulator is indirectly involved in controlling the expression of XplA in 11Y, which is 
linked to central nitrogen metabolism.     
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Chapter 1 
Introduction 
1.1 An overview of explosives 
The development of organic chemistry has led to the synthesis of broad ranges of 
novel organic compounds, one group of which are explosives. An explosive is defined 
as “a chemical compound, or a mixture of compounds, that can be initiated to generate 
rapid expanding gases, heat, light and an enormous pressure” (Akhavan, 2004). The 
discovery and development of explosives have been described in detail by Akhavan 
(Akhavan, 2004) and briefly in Table 1.1.  
Blackpowder was probably the first explosive composition that was, almost certainly 
accidently, discovered by Chinese alchemists in 220 B.C. Blackpowder was made up 
from charcoal, sulphur and potassium nitrate (Akhavan, 2004). The recipe for 
blackpowder was introduced into Europe where it was first made in 1249, by Robert 
Bacon (England). Later, Hungary, Germany, England and Sweden all used 
blackpowder in mining and tunnelling operations. 
The discovery of nitric and sulfuric acids allowed chemists to produce explosives via a 
nitration technique (Bailey and Murray, 2000), resulting in production of three classes 
of powerful explosives: nitrate esters, nitroaromatics and nitramines (Figure 1.1).  
Glycerol trinitrate (GTN) was the first nitrate ester explosive and was discovered by an 
Italian Ascanio Sobrero in 1846. Few years later, Immanuel Nobel developed a method 
to generate GTN by mixing of glycerol, nitric acid and sulfuric acid. Although it was a 
powerful explosive, it was chemically unstable; an undesirable characteristic which led 
to the accidental demolition of a GTN factory (Akhavan, 2004). The second nitrate 
ester explosive, pentaerythritol tetranitrate (PETN) was developed by nitration of 
pentaerythritol in 1894. Similar to GTN, PETN was chemically unstable and was used 
in combination with other more stable explosives such as trinitrotoluene (TNT).  
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Picric acid (2,4,6-trinitrophenol) is a nitroaromatic explosive. It was initially used as dye 
for wool and silk. Its property as explosive was discovered in 1830 by Welter who 
demonstrated its synthesis by reacting nitric acid with indigo or phenol. Picric acid is a 
strong acid, soluble in benzene, acetone and water, and more stable than GTN. Since 
1894, it has been used as a military explosive worldwide. The problem with picric acid 
is that it easily reacts with the shell walls resulting in corrosion (Akhavan, 2004). 
Another example of a nitroaromatic explosive is 2,4,6-trinitrotoluene (TNT), discovered 
by Joseph Wilbrand in 1863. By sequential nitration reactions of toluene, 
mononitrotoluene, then dinitrotoluene and finally TNT can be produced. TNT was the 
dominant explosive used in World War I (Lewis et al., 2004) and is still being used 
today. This is due to the advantageous properties of TNT including its high thermal 
stability, low production costs and ability to be pressed and moulded into shells. In 
addition, it is compatible with other explosives. Examples of military and commercially 
used explosive compositions that include TNT are Minol-2 (40 % TNT, 40 % 
ammonium nitrate and 20 % aluminium), Pentolites (50 % PETN and 50 % TNT) and 
Picratol (52 % Picric acid and 48 % TNT).  
The hexahydro-1,3,5-trinitro-1,3,5-triazine: Royal Demolition Explosive (RDX) is a 
powerful nitramine explosive (Figure 1.1). Its explosive property was first observed by 
Herz in 1920 and its high chemical and thermal stabilities meant that it became widely 
used during World War II. A technical problem was that due to its high melting point, 
RDX was difficult to pour into shells. To overcome this problem, RDX was mixed with 
TNT to lower the melting temperature to make the explosive mixture pourable. 
Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine; High Melting Explosive (HMX) is also 
a member of the nitramine explosives. HMX has a higher melting point than RDX (RDX 
melting temperature: 200 °C; HMX melting temperature: 275 °C). HMX has similar 
characteristic to RDX in that they are both chemically stable and have similar explosive 
power.  
Decades of military activities across the globe including World War I and II have 
caused widespread land and groundwater contaminations. TNT and RDX are the most 
widely used explosives and these explosives are difficult to degrade and thus persist in 
the environment for decades. The scale of contamination by explosives is described in 
the following section.  
 24 
 
Table 1.1. Key events of the discovery and development of explosives. 
Date                 Event 
220 BC            Blackpowder accidently discovered by Chinese alchemists  
1169                Fireworks were made by Chinese 
1249                Blackpowder was first synthesised in England 
1320                Blackpowder was introduced to central Europe 
1830                Picric acid was discovered as an explosive 
1846                Glycerol trinitrate was discovered by Ascanio Sobrero 
1863                Glycerol trinitrate was manufactured by Immanuel Nobel  
1863                TNT was produced by Joseph Wilband 
1891                TNT was manufactured in Germany 
1894                PETN was synthesised in Germany 
1902                Picric acid was replaced by TNT in Germany  
1920                RDX was discovered as an explosive by Herz 
1925                RDX was largely produced in U.S. 
1945                HMX was synthesised by Bachmann 
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1.2 Contamination of the environment by 
explosives 
The precise figure on the amount of explosives produced globally is unclear, but it is 
known that more than 5.5 billion pounds of explosives are produced each year in 
United States (U.S. Government Accountability Office, 2005). The U.S. Department of 
Defense predicts the production and use of explosives will be continuing on this scale 
(Wiesmann et al., 2007). The massive production, use and storage of explosives have 
led to serious contamination of the environment. In the United States alone, 
approximately 50 million acres (20.2 million hectares) of soil have been contaminated 
by explosives (Clausen et al., 2004) and around 17,000 sites on U.S. military training 
ranges have been identified that require clean up (Gunnison et al., 1999). Current 
clean up methods are incomplete and expensive and the estimated treatment cost 
could reach U.S. $165 billion (http://www.dtic.mil/cgi-
bin/GetTRDoc?AD=ADA435939&Location=U2&doc=GetTRDoc.pdf).  
The characterisation of explosives contaminated sites in the United States has been 
extensively carried out by the Department of Defense under an environmental research 
program, namely Strategic Environmental Research and Development Program 
(SERDP). Of the explosives polluted sites, military training ranges at Massachusetts 
Military Reservation (MMR) located near Falmouth, are amongst the better 
characterised sites (Clausen et al., 2004). Analysis of more than 15,000 environmental 
samples revealed MMR has been contaminated by explosives and their derivative 
compounds (Figure 1.2). The sole-source drinking water aquifer was also found to be 
polluted by RDX, affecting more than half a million residents and visitors around the 
MMR area. Due to the contamination of water supplies by the explosives, the U.S. 
Environmental Protection Agency (EPA) has restricted the military activity at MMR.      
The U.S. EPA classifies TNT as a group C possible human carcinogen (Craig et al., 
1995). Studies showed TNT to be mutagenic to Salmonella typhimurium (Berthe-Corti 
et al., 1998, Honeycutt et al., 1996), hamster and rat cell lines (Honeycutt et al., 1996). 
TNT has also been reported to be toxic to marine mussels (Rosen and Lotufo, 2007), 
plants (Gong et al., 1999, Hannink et al., 2001) and sea urchin (Nipper et al., 2001). 
Similar to TNT, RDX is classified as a class C possible carcinogen. The mutagenic 
effects of RDX and its breakdown compounds hexahydro-1-nitroso-3,5-dinitro-1,3,5-
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triazine (MNX) and hexahydro-1,3,5--trinitroso-5-nitro-1,3,5-triazine (TNX) in S. 
typhimurium indicated these compounds weakly induced mutagenesis (Pan et al., 
2007). RDX is toxic to tested organisms such as fish (Lotufo et al., 2010), plants (Rylott 
et al., 2006) and bacteria (Flokstra et al., 2008); however, it is less toxic compared to 
TNT. HMX is classified as a group D non-classifiable carcinogen (Craig et al., 1995). A 
study showed that at a nearly saturated concentration of HMX (10 µM), it failed to 
cause toxic effects when exposed to mussels (Rosen and Lotufo, 2007). 
Bioconcentration analysis using fish (Cyprinodon variegatus) as model demonstrated 
low potential for HMX to bioaccumulate in the fish (Lotufo et al., 2010).  
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Figure 1.2. Explosives detected in the contaminated sites at the Camp Edwards, 
Massachusetts Military Reservation, MA (Clausen et al., 2004).  
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1.3 Remediation technologies 
1.3.1 Incineration 
Incineration is a waste treatment method that has been used to remediate explosive 
contaminated soils. It can remove explosives efficiently and is a time-saving treatment 
method. This method required high temperature (at least 850 °C) to convert waste 
materials into ash, gases and heat (Waterland et al., 1991). There are several 
drawbacks to this method: it produces toxic gases including dioxins, nitrous oxides, 
carbon monoxide, sulphur dioxide and hydrogen chloride (Beychok, 1987, van Ham, 
1998), the humic component of the soil is destroyed leaving the soil biologically barren, 
the soil has to be transported to the incinerator and the cost for this method is very 
high; estimates range between U.S. $400 to U.S. $1400 per ton (Craig et al., 1995). 
Although incineration is an efficient treatment, the cost would be incredibly high if all of 
the soils contaminated with explosives were treated using this technology.  
1.3.2 Bioremediation 
1.3.2.1 Composting  
Composting is a biological treatment technique that has been used to remediate 
explosives contaminated soils. The contaminated soils are mixed with organic waste, 
such as agricultural waste, manures, fruit or vegetable processing wastes to provide 
nutrient source for the indigenous microorganisms (Craig et al., 1995). Efficient 
composting depends on a variety of factors including pore space in the compost 
system, moisture content, waste particle size, temperature, pH and aeration (Ro et al., 
1998, McMahon et al., 2008). The treatment cost of this technique (U.S. $100 per ton) 
is cheaper than incineration (Ro et al., 1998) and, unlike incineration, composting does 
not produce hazardous gases and is therefore well accepted by public. However, like 
incineration, it is difficult to treat large (>hectares) of soil with this method. Pilot scale 
studies have demonstrated that composting can effectively remove explosives from 
soils (Craig et al., 1995), but the fate of the explosives during composting is still an 
important aspect that remains to be investigated. As the transformation or degradation 
of explosives in the contaminated soils by composting mainly depends on the microbial 
activities, understanding the biotransformation and mineralisation pathways of 
explosives in single pure culture isolated from explosives contaminated sites is 
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essential. The knowledge gained from these studies would enhance our understanding 
about the fate of the explosives in the composting process.     
1.3.2.2 Biostimulation 
Biostimulation is a biological approach to remediate explosive contaminated sites by 
adding nutrients and/or electron donors (acetate, soluble starch, ethanol and other 
carbon materials) (Davis et al., 2004). Numerous ex situ techniques have been 
employed to remediate explosive contaminated groundwater including bioreactors, 
granular activated carbon units and UV-oxidation reactors (Fuller et al., 2007, ESTCP, 
2008). However, these techniques have high costs due to the pumping and re-injection 
of treated water to the water source. In situ biostimulation method offers a cheaper 
technique over other treatments. One example is using organic mulch. Organic mulch 
is a complex carbon material that typically contains indigenous bacteria. It has been 
employed to treat explosive-contaminated groundwater over a decade (ESTCP, 2008). 
Indigenous microorganisms in the organic mulch breakdown the complex organic 
materials to release soluble carbon sources which are further utilised by the same or 
other microorganisms as an electron donor for treating the explosives via the reductive 
pathways (Figure 1.4). Bench-scale and on-site studies using organic mulch permeable 
reactive barriers have revealed promising results in remediating the polluted 
groundwater (Ahmad et al., 2007, ESTCP, 2008).  
1.3.2.3 Phytoremediation 
Phytoremediation refers to the use of plants to clean-up pollutants from the 
environment. This technique is an inexpensive alternative treatment to incineration and 
composting. Plants are robust and have good root systems to reach the pollutants; 
however, often contaminants are phytotoxic to plants. These limitations can be 
overcome by genetic engineering approach: expressing recombinant bacterial genes in 
plants to produce transgenic plants that are able to detoxify or degrade the 
contaminants. A number of studies demonstrated that transgenic plants dramatically 
improved the tolerance and biotransformation ability of plants to contaminants (Rugh et 
al., 1998, French et al., 1999, Hannink et al., 2001, Rylott et al., 2006, Hannink et al., 
2007, Jackson et al., 2007, Rylott and Bruce, 2009). The enzyme nitroreductase (NR) 
from Enterobacter cloacae has been shown to be able to biotransform TNT (Bryant and 
DeLuca, 1991). NR-expressing plants significantly increased TNT biotransformation 
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rates by 30-fold when compared to untransformed plants grown in liquid medium. The 
NR-expressing plants also appeared healthy and gained weight at TNT concentration 
of 0.5 mM (Hannink et al., 2001) while unmodified plants died.  
The cytochrome P450 enzyme XplA, and, reductase partner, XplB were isolated and 
shown to be responsible for RDX degradation in Rhodococcus rhodochrous 11Y (Seth-
Smith et al., 2002, Jackson et al., 2007). Rylott and co-workers (2006) successfully 
expressed XplA individually and together with XplB in Arabidopsis plants. Soil studies 
showed that the XplA-expressing plants were able to grow healthily in the presence of 
up to 2,000 mg RDX/kg soil while unmodified plants exhibited signs of toxicity. Double 
transgenic plants that expressing both XplA and XplB were able to further enhance the 
RDX degradation (Jackson et al., 2007). HPLC analysis demonstrated up to three 
times more RDX accumulated in root tissues of unmodified plants than transgenic 
plants. Low level of RDX accumulation in transgenic plants and higher tolerance 
towards RDX suggested XplA degrades RDX in plants.  
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1.4 Microbial transformation of TNT 
The nitroaromatic TNT is recalcitrant to degradation and persists in the environment. 
Bacteria are able to transform TNT under both aerobic and anaerobic conditions 
(French et al., 1998, Pak et al., 2000, Esteve-Nunez et al., 2001, Eyers et al., 2008, 
Rylott et al., 2011) but so far no reports suggest that complete degradation of TNT 
occurs. The mineralisation of TNT is challenging as multiple electro-withdrawing nitro 
groups are present in TNT, prevent oxidative attack on the ring that generally leads to 
the ring cleavage of aromatic compound.  
The majority of TNT-transforming bacteria tend to reduce one or two of the nitro groups 
of TNT to produce nitroso, hydroxylamino and amino derivatives (Route 1, Figure 1.3). 
Azo dimers formed from hydroxylamino and amino derivatives of TNT have also been 
observed (Lewis et al., 1997). Nitroreductases are responsible for the TNT 
transformation illustrates in Route 1, Figure 1.3 (Rylott et al., 2011). Another TNT 
transformation pathway was found to be catalysed by members of the Old Yellow 
Enzyme family (Williams et al., 2004). It involves a hydrogenation reaction of the 
aromatic ring to produce a Meisenheimer complex. (Route 2, Figure 1.3). Recent 
studies further elucidate the TNT transformation pathway by these flavoprotein 
oxidoreductase, demonstrating that diarylamines and nitrite are formed from the 
condensation of hydroxyamino derivatives with dihydride Meisenheimer complexes 
(Figure 1.3)(Wittich et al., 2008, Wittich et al., 2009).  
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Figure 1.3. TNT degradation pathways. Route 1. TNT transformation via reduction of nitro 
groups. Route 2. TNT transformation via hydrogenation of TNT to produce Meisenheimer 
complex (Lewis et al., 1997, French et al., 1998, Wittich et al., 2008).   
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1.5 RDX 
Royal Demolition Explosive (RDX), also known as hexogen, cyclonite and T4, is one of 
the most powerful explosives. It was extensively used during the World War II and 
nowadays more than 4000 military items are reported to contain RDX (U.S. EPA, 
2011). RDX has a low soil sorption coefficient (Koc) values indicating that it is not easily 
retained by soil and easily migrates through soils to reach groundwater (Table 1.2). 
The power index of RDX is 169 % relatively to picric acid (Table 1.2).  The structure of 
RDX is unique because of the attachment of the nitro group to the central ring via 
nitrogen-nitrogen bonds (Fig 1.1). To date, the nitrogen-nitrogen bond formation occurs 
rarely in nature. This unusual feature makes RDX resistant to biological attack.  
 
Table 1.2. Physical and chemical properties of RDX (EPA, 2011). 
               
 
  
 
 
 
 
 
 
 
Property                                                                     Value 
 
Physical description       White Crystalline Solid 
Molecular weight (g/mol)                                             222 
Water solubility (mg/L at 20 °C)                                  42 
Soil organic carbon-water coefficient (Koc)                 1.8  
Melting point (°C)                                                        206 
Power index (%)                                                         169 
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1.5.1 Microbial degradation of RDX 
Although RDX is recalcitrant to degradation, bacteria in the environment are still able to 
adapt themselves to transform RDX, and as a result utilise it as a nitrogen source for 
growth. Documentation of microbial RDX degradation began around 30 years ago. To 
date, three RDX biodegradation pathways have been postulated: two-electron 
reduction, single-electron reductive denitration and direct RDX ring cleavage.  
The two-electron reductive pathway was proposed by McCormick and co-workers 
(1981). When sewage sludge was incubated in medium containing 450 µM RDX 
anaerobically, all of the RDX was removed after four days of incubation. The nitroso-
derivatives: hexahydro-1-nitroso-3,5-dinitro-1,3,5-triazine (MNX), hexahydro-1,3-
dinitroso-5-nitro-1,3,5-triazine (DNX) and hexahydro-1,3,5-trinitroso-5-nitro-1,3,5-
triazine (TNX) were detected, indicating the pathway occurred via RDX reduction 
(Figure 1.4; Route 1). Further transformation of these metabolites produced ring 
cleavage products, namely formaldehyde, methanol (CH3OH) and hydrazine (H2N-
NH2). These nitroso metabolites were also observed by Hawari and co-workers (2000) 
when similar experiments were performed using municipal anaerobic sludge. In 
addition, two novel intermediate products were also detected by liquid 
chromatographic/mass spectroscopic: methylenedinitramine (MEDINA) and 
bis(hydroxylmethyl)nitramine, suggesting another putative RDX transformation pathway 
via direct ring cleavage of RDX (Figure 1.4; Route 2). The authors suggested that both 
metabolites were further transformed to produce nitramine (NH2NO2) and formaldehyde 
(HCHO). Nitramine was likely to be transformed spontaneously in water to yield N2O 
and the formaldehyde was further transformed to HCOOH and eventually to CO2 in 
sludge (Hawari et al., 2000).  
Pure bacterial isolates of Klebsiella pneumoniae strain SCZ-1 (Zhao et al., 2002), 
Clostridium bifermentans strain HAW-1 (Zhao et al., 2003), Citrobacter sp. (Kitts et al., 
1994) and Morganella sp. (Kitts et al., 1994) were found to transform RDX via this 
reductive route yielding nitroso-RDX (MNX, DNX and/or TNX) and different RDX 
mineralisation activities were observed in these isolates (between 3 % and 72 %). It 
was proposed that a type I nitroductase enzyme initiated the transformation of RDX via 
two-electron reductive pathway in sludge (Hawari et al., 2000). Enterobacter cloacae 
type I nitroreductase was expressed in Escherichia coli (E. coli) and whole cell assays 
demonstrated approximately 5-fold higher RDX nitroreductase activity in induced cells 
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compared to uninduced cells. In vitro studies confirmed type I nitroreductase could 
transform RDX, however, details for intermediates were not provided by the authors 
(Kitts et al., 2000). 
The single-electron reductive denitration of RDX was found to be another pathway in 
RDX degradation (Crocker et al., 2006). This route involves a one-electron transfer 
step subsequently releasing a nitro group from RDX. The removal of the nitro group 
leads to the formation of an unstable free-radical RDX followed by ring cleavage to 
release other intermediate products (Crocker et al., 2006). The degradation products 
via the denitration pathway were slightly different under aerobic and anaerobic 
conditions, with production of 4-nitro-2,4-diazabutanal (NDAB) and MEDINA under 
aerobic and anaerobic conditions, respectively. Klebsiella pneumoniae strain SCZ-1 
was able to transform RDX via both denitration and reduction pathways under 
anaerobic conditions (Zhao et al., 2002). Strain SCZ-1 degraded RDX to produce 
methanol (12 % of total carbon), nitrous oxide (60 % of total nitrogen), carbon dioxide 
(72 % of total carbon) and transient products of formaldehyde, MNX and MEDINA.  
More than 25 isolates have now been isolated that are able to transform RDX 
aerobically via the denitration pathway (Coleman et al., 2002, Seth-Smith et al., 2002, 
Thompson et al., 2005, Nejidat et al., 2008, Seth-Smith et al., 2008, Andeer et al., 
2009). Almost all of the isolates belong to the Rhodococcus genus in the 
Corynebacterineae (Coleman et al., 2002, Nejidat et al., 2008, Seth-Smith et al., 2008, 
Seth-Smith et al., 2002, Bernstein et al., 2011). Examples are Rhodococcus 
rhodochrous 11Y, Rhodococcus sp. strain DN22 and Rhodococcus strain YH1. 
Biodegradation of RDX in Rhodococcus sp. strain DN22 is amongst the better 
characterised strains (Fournier et al., 2002, Annamaria et al., 2010). Resting cell 
studies of strain DN22 under aerobic condition generated metabolites of NO2-, NO3-, 
MEDINA, NDAB, N2O, CO2, NH3 and HCHO. The authors proposed initial denitration 
taking place resulting in production of single-denitrated and double-denitrated 
metabolites (I and II, Figure 1.5). Following the ring cleavage, NDAB, MEDINA, 
diformylamide and formamide were produced. NDAB was found to be stable under 
ambient conditions, but MEDINA was unstable and readily decomposed to HCHO and 
N2O. Diformylamide and formamide via the secondary biotic reactions were further 
degraded to yield NH3, HCOOH and CO2 (Figure 1.5). Experiments with radio-labeled 
oxygen atom in water (H218O) and oxygen gas (18O2) revealed oxygen atoms in both 
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water and oxygen gas were not directly involved in the initial denitration process, but 
one 18O atom from oxygen gas was incorporated in NO3-. Also, an 18O atom from water 
was detected in the ring cleavage product NDAB (Annamaria et al., 2010).  
Involvement of a cytochrome P450 in RDX biodegradation was initially proposed by 
Coleman and co-workers (Coleman et al., 2002). The authors found that RDX 
degradation in strain DN22 was inhibited when metyrapone (P450 inhibitor) was added 
in the resting cell assays. Seth-Smith et al., (Seth-Smith et al., 2002) was the first 
group to successfully isolate the gene responsible for RDX degradation, xplA, which 
encodes a novel flavodoxin fused cytochrome P450 from R. rhodochrous 11Y, and was 
later used for the phytoremediation studies described above. xplA is conserved 
amongst the RDX degrading bacteria (Coleman et al., 2002, Nejidat et al., 2008, 
Andeer et al., 2009). The RDX degrading P450, XplA has been functionally 
characterised and the structure of XplA heme domain has been successfully resolved 
(Jackson et al., 2007, Sabbadin et al., 2009), which are described in following sections.   
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Figure 1.4. Proposed anaerobic RDX degradation pathways with anaerobic sludge 
(McCormick et al., 1981, Hawari et al., 2000). 
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Figure 1.5. RDX degradation pathway in Rhodococcus strain DN22 (Annamaria et al 
2010). Intermediates in brackets indicate hypothetical denitrated (I and II) compounds. Dashed 
lines (grey) refers to abiotic reactions; dashed lines (black) refers to biotic reactions. Figure is 
taken from Annamaria et al., (2010).   
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1.6 RDX degradation by commercial enzymes  
Some commercially available enzymes have been employed to investigate the 
transformation pathways of RDX (Bhushan et al., 2002, Bhushan et al., 2003). An 
NADPH dependent nitrate reductase from Aspergillus niger was shown to be able to 
catalyse the transformation of RDX under anaerobic conditions. This was the first 
report that a nitrate oxidoreductase was able to transform nitramine compounds 
(Bhushan et al., 2002). The activity of this enzyme toward RDX was inhibited in 
presence of nitrate.  
Analysis of the intermediate compounds showed the MNX and a ring cleavage 
metabolite MEDINA were formed. These compounds then disappeared in the reaction 
mixtures followed by the appearance of nitrous oxide, formaldehyde and ammonium 
ion. No DNX and TNX were observed throughout the experimental time. Similar 
experiments were conducted using MNX as substrate and showed that DNX and TNX 
were not detected, suggesting that the ring cleavage occurred via MNX (Bhushan et 
al., 2002), which also indicates the possibility of another route of RDX transformation 
under anaerobic condition compared with the previously described pathway (Figure 
1.4; Route 1).  
Another RDX degrading commercially available enzyme is rabbit liver cytochrome 
P450 2B4 (Bhushan et al., 2003). This enzyme was initially found to be able to remove 
the alkyl group from pentoxyresorufin. Incubation of P450 2B4 with RDX and NADPH in 
presence of oxygen showed a similar distribution of RDX intermediates to that of 
Rhodococcus strain DN22. Based on the detection of metabolites and mass balance 
analyses, it was proposed that RDX degradation by P450 2B4 underwent initial two 
steps of denitration followed by ring cleavage to produce NDAB and formaldehyde 
(Bhushan et al., 2003).  
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1.7 Rhodococcus rhodochrous 11Y 
Rhodococcus rhodochrous strain 11Y was isolated from soil taken from a polluted 
explosives manufacturing facility based on its ability to use RDX as a sole nitrogen 
source for growth. To isolate the gene that was responsible for RDX degradation in 
strain 11Y, a gene library from this strain was constructed and cloned into the 
Escherichia coli - Rhodococcus shuttle vector pDA71. This library was transferred into 
Rhodococcus strain CW25, a non-RDX degrading strain (Seth-Smith, 2002).  
Following the screening of library clones in liquid minimal medium with RDX as the sole 
nitrogen source, and further selection on RDX dispersion agar, four recombinant CW25 
strains that were able to degrade RDX were isolated. The pDA71 construct from these 
strains was sequenced and was found to possess a 7.5 kb of insert was present in all 
four of the recombinant CW25 strains. The construct was designated as pHSX1. 
Sequence analysis of the 7.5 kb insert revealed the presence of three open reading 
frames encoding a cytochrome P450 system, a reductase and acetyl CoA synthase 
(Figure 1.6). 
Further subcloning to produce pHSX1a and pHSX1b was performed (Figure 1.6). The 
recombinant CW25 containing pHSX1b was found to be able to degrade RDX 
confirming that the cytochrome P450 system was responsible for RDX degradation and 
the P450 was named xplA, for explosive degrading. The gene encoding the 
neighbouring reductase was named xplB.   
Sequence analysis revealed that xplA encodes a new class of cytochrome P450 
system which comprises a flavodoxin domain fused to the N-terminus of this P450 
system (Seth-Smith et al., 2002). The xplB gene adjacently upstream of xplA encodes 
an open reading frame, with highest similarity to bovine mitochondrial adrenodoxin 
reductase (27 % identity and 42 % similarity) (Seth-Smith, 2002).  
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Figure 1.6. The gene cluster isolated from strain 11Y contains genes responsible for RDX 
degradation (Seth-Smith, 2002).  
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1.8 Characterisation of XplA and XplB 
Soluble expression of 11Y XplA in E. coli was achieved and the characteristics of 
purified XplA as a cytochrome P450 were confirmed by spectral analysis in which the 
Soret peak was shown to shift from 420 nm to 448 nm when reduced in the presence 
of carbon monoxide (Jackson et al., 2007). Trypsin digestion and tandem mass 
spectrometry (MS/MS) analysis revealed the presence of flavodoxin and P450 
domains, thus confirming XplA is a flavodoxin fused cytochrome P450 (Rylott et al., 
2006). Active XplB was obtained as a GST fusion and cleavage of the GST from 
purified XplB-GST fusion caused protein precipitation. The flavin cofactors from XplA 
and XplB were released after a boiling step and HPLC analysis confirmed that XplA 
contains flavin mononucleotide (FMN) and XplB contains flavin adenine dinucleotide 
(FAD) (Jackson et al., 2007).  
In vitro assays using XplA and XplB demonstrated RDX degradation pathways depend 
on the presence or absence of oxygen (Figure 1.7). Under aerobic conditions, the 
ratios of nitrite to RDX was 2.49:1.00 and the formaldehyde to RDX was 1.26:1.00 at 
70 min. While NDAB was detected and continued to accumulate to a ratio of 1:1 
(NDAB:RDX); MEDINA was not detected. Under anaerobic conditions, the ratios of 
nitrite to RDX was 1.4:1.0 and formaldehyde to RDX was 1.96:1.00. MEDINA was 
detected with a ratio of 0.68:1.00, as a transient metabolite (Jackson et al., 2007). 
Based on the metabolite distribution, it was proposed that under aerobic condition, two 
steps of denitration of RDX occur resulting in the release of two moles of nitrite 
followed by spontaneous ring cleavage to produce NDAB and formaldehyde. Under 
anaerobic condition, a single step of denitration of RDX was followed by ring cleavage 
to produce MEDINA and formaldehyde. These pathways are found to be in agreement 
with previously described RDX degradation pathways by resting cells (Fournier et al., 
2002, Annamaria et al., 2010).   
A wider range of substrate screening revealed that XplA does not transform HMX and 
TNT and no hydroxylation activity was detected when the common P450 substrates 
testosterone or paclitaxel were used. However, XplA was able to oxidise methyl tolyl 
and methyl phenyl sulphides to sulfoxide products implying it could act as a 
monooxygenase albeit poorly. Inhibition studies demonstrated TNT and methyl tolyl 
sulphide inhibited RDX activity (Jackson et al., 2007).  
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Figure 1.7. Proposed RDX degradation pathway by XplA and XplB   
XplA is unusual in that it possesses a flavodoxin domain fused at the N terminus of the 
P450. Electrons transfer from NADPH to the heme domain via the reductase (XplB) then to 
the flavodoxin domain of XplA. The presence of oxygen alters the route of degradation. 
Under anaerobic condition, methylenedinitramine (MEDINA), nitrite and formaldehyde are 
produced. Under aerobic condition, 4-nitro-2,4, diazabutanal (NDAB), nitrite and 
formaldehyde are produced.      
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1.9 The XplA-heme structure  
The heme domain of P450 XplA is a prism structure with dimensions of 50 x 50 x 60 Ǻ. 
The overall structure of XplA-heme is conserved across other P450 hemes, including 
the α helices-rich large domain and β strands-rich small domain (Fig. 1.8). However, 
XplA-heme possesses a number of unique features that make it differ from other 
P450s. While the long I helix, which directly contacts the heme, is conserved in other 
P450s, a break in the central region of the I helix in XplA-heme is observed (Fig. 1.8).  
The iron in the active site is coordinated in the 5-position by the conserved Cys-503 
(Fig. 1.9). The active site environment of XplA contains Trp-230, Trp-224, Phe-540, 
Leu-238, Val-387, Val-391, Ala-395, Pro-437 and methionine cluster (Met-318, Met-
322, Met-394), forming a highly hydrophobic pocket. Interestingly, Met-394 and Ala-395 
replaces the pair, commonly an acidic residue followed by threonine (or serine) in other 
P450s and are thought to be involved in oxygen activation. Due to the fact the RDX 
denitration by XplA does not require oxygen; the absence of threonine is important in 
RDX degradation. Site directed mutagenesis to directly replace Ala-395 to threonine 
increased Km (4-fold higher than wild-type enzyme) and significantly decreased of Kcat 
(50-fold lower than wild-type enzyme). When Met-394 was mutated to leucine, a two 
fold decrease was observed in Kcat/Km compared with wild-type enzyme (Sabbadin et 
al., 2009).       
Two putative channels for ligand transport are found leading to the XplA-heme active 
site (Fig. 1.10). It is observed that in the larger channel, a chain of seven water 
molecules leads from the surface of the enzyme into the side chain of Gln-438, located 
close to the heme active site. The second channel is bounded by the side chains of 
Arg-288 and Arg-545 and a positively charged patch is observed on the surface of this 
channel, probably responsible for the capturing of the RDX. Although the structure of 
RDX bound to XplA-heme could not be obtained, the XplA-heme soaked with RDX 
revealed significant movement of residues (Arg-288, Arg-543 and Arg-545) at second 
putative channel, suggesting that RDX is likely entering the heme area via this channel 
(Fig. 1.10). 
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Figure 1.8. Topology of XplA-heme revealing the well conserved secondary elements. 
The α helices are represented in red. The β strands are represented in yellow and green. The 
black circle refers to the iron at the heme active site. Figure is taken from Sabbadin (2010).        
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Figure 1.9. The active site and XplA-heme environment. Imidazole is bound on the heme 
active site. Residues surrounding the heme including Trp-230, Trp-224, Phe-540, Leu-238, Val-
387, Val-391, Ala-395, Pro-437 and methionine cluster (Met-318, Met-322, Met-394), forming a 
hydrophobic celling of the heme binding site. Figure is taken from Sabbadin (2010).        
 
 
 
 
 
 
 
 
Figure 1.10. The putative transport channels are shown in grey. The movement of residues 
(Arg-288, Arg-543 and Arg-545) are observed in protein crystals soaked with RDX. Figure is 
taken from Sabbadin (2010).          
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1.10 RDX degrading gene cluster 
Analysis using PCR with primers specific to the xplA and xplB sequences from R. 
rhodochrous strain 11Y yielded products in all of the Rhodococcus strains HS1-19 
except strain HS4 (Seth-Smith et al., 2008). Partial sequencing of the PCR products 
showed more than 99 % nucleotide identity to xplA and xplB. Homologues (also with 
>99 % identity) of xplA and xplB have also been described for Rhodococcus sp. strain 
DN22 from Australia (Bhushan et al., 2003), strain YH1 from Israel (Nejidat et al., 
2008), and Gordonia sp. strain KTR9 (Thompson et al., 2005) and Williamsia sp. strain 
KTR4, from North America (Indest et al., 2007). No XplA homologues have so far been 
detected in environments uncontaminated by explosives.  
A fosmid library was constructed from Microbacterium sp. MA1, an RDX degrading 
bacterium from the U.S. and a 52 kb plasmid DNA sequence flanking xplA/B was 
isolated (Andeer et al., 2009). Sequence analysis of this DNA sequence flanking xplA/B 
revealed that the RDX degrading gene cluster from Rhodococcus rhodochrous 11Y in 
the U.K shares near identical sequences to the open reading frame (ORF) 30 to 34 in 
Microbacterium sp. MA1 (Figure 1.11) (Andeer et al., 2009). 
By means of chromosome walking upstream of ORF 30 in Rhodococcus rhodochrous 
11Y (Dr Cyril Bontemps and Dr Astrid Lorenz, personal communication), sequence 
analysis revealed ORF 27 and ORF 29 were also identical with the DNA sequence 
flanking xplA/B from Microbacterium sp. MA1 (Figure 1.11). The ORF 27 and ORF 29 
encode a putative transcriptional regulator and a putative transporter, respectively. The 
putative regulator is characterised as a repressor with homology to the regulatory 
protein MarR, a multiple antibiotic resistance regulator. The putative transporter was 
found to display close homology to amino acid permease from Mycobacterium 
vanbaalenii PYR-1. 
Another RDX degrading gene cluster was isolated from Gordonia sp. strain KTR9 
(Indest et al., 2010). This gene cluster revealed the presence of four open reading 
frames encoding XplA, a fusion of glutamine synthase with XplB, a second cytochrome 
P450 (Cyp151C) and XplR, a GntR-type regulator (Figure 1.12). Whole cell studies 
demonstrated the XplA - expressing E. coli degraded RDX but the Cyp151C - 
expressing E. coli did not. The function of the XplB fusion and the putative regulator 
XplR was not investigated (Indest et al., 2010).  
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Recently, PCR analysis showed that the newly isolated RDX degrading Rhodococcus 
spp. (Belgium and UK) and strain Rhodococcus DN22 (Australia) also share near 
identical sequences from ORF 27 to 34 (Fig. 1.11) in Rhodococcus rhodochrous 11Y 
(Dana Sabir, personal communication). The highly conserved nature of the RDX 
degrading gene cluster from geographically distinct region suggests this gene cluster 
may have been transferred via a horizontal gene transfer mechanism.  
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Figure 1.11. Sequence comparison of gene clusters flanking xplA/B isolated from 
Rhodococcus rhodochrous 11Y (cluster A) and Microbacterium sp. MA1 (cluster B) 
(Andeer et al., 2009).  
 
 
 
 
 
 
 
Figure 1.12. RDX gene clusters flanking xplA isolated from Gordonia sp. strain KTR9. 
xplR, cyp151C, glnAxplB and xplA encoding a putative regulator, a cytochrome P450, fusion 
reductase and RDX degrading P450 enzyme, respectively (Indest et al., 2010). 
 
 
 
ORF27: Putative transcriptional regulator with homology to regulatory protein MarR 
ORF28: Transposase, tnpA. The only ORF in IS element ISMA1 
ORF29:Putative transporter with homology to amino acid permease from Mycobacterium 
vanbaalenii PYR-1 
ORF30: Putative dihydrodipicolinate reductase 
ORF31: xplB, encodes a flavodoxin reductase partner for xplA 
ORF32: xplA, encodes novel cytochrome P450 (CYP177A1, XplA) with flavodoxin domain  
ORF33: Aldehyde dehydrogenase C-terminus domain protein 
ORF34: Acetyl CoA synthase 
ORF35: Transposase pseudo gene  
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1.11 Aims  
As described in the previous sections, contamination of the environment by the 
explosive RDX is a global problem. Up to present, xplA is the only P450 gene that has 
been identified as responsible for RDX degradation. The XplA/B is encoded on an 
operon in Rhodococcus rhodochrous strain 11Y and the gene cluster is highly 
conserved amongst other RDX degrading bacteria from geographically distinct regions. 
The isolation of new RDX degrading gene(s) is an area of particular interest as other 
RDX degrading strains are likely to exist.  
Therefore, the first aim of this project was to gain a better understanding of the RDX 
degrading system in Rhodococcus erythropolis strain HS4, which could potentially 
have an alternative RDX degrading system. Previous studies by Dr. Seth-Smith (2002) 
showed the RDX activity in strain HS4 was inhibited by metyrapone, an inhibitor of 
P450 enzyme. Southern blot and PCR analysis indicated that xplA and xplB were 
absent in strain HS4. Further characterisation of the RDX degradation in strain HS4 
was attempted.  
To date, the xplA/B gene cluster has not been characterised. The second aim was to 
analyse the genes on the operon with respect to RDX metabolism in strain 11Y. An 
unmarked gene deletion system (van der Geize et al., 2001) was employed to 
sequentially knockout xplA, xplB, putative permease and the putative regulator on the 
11Y gene cluster to produce four knockout strains. These knockout strains were 
characterised relative to wild-type. In addition, the putative permease was also 
heterologously expressed in E. coli and RDX uptake assays performed.  
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Chapter 2 
General methods 
2.1 Suppliers 
All reagents, chemicals and DNA modifying enzymes were purchased from Sigma-
Aldrich (Gillingham, UK), GE Healthcare (Pollards Wood, UK), Promega (Southampton, 
UK), New England Biolabs (Hitchin, UK), Merck (Nottingham, UK), Qiagen (West 
Sussex, UK), Fisher Scientific (Loughborough, UK), Expedeon (Cambridge, UK), 
Applied Biosystems (Paisley, UK) and Invitrogen (Paisley, UK).   
RDX (>95 % purity) was kindly provided by the Defence Science and Technology 
Laboratory, Fort Halstead, U.K. 
Oligonucleotide primers used in this study were synthesised by Sigma-Genosys Ltd 
(UK) (Table 2.1).   
2.2 Media 
2.2.1 Minimal medium 
Minimal medium (pH 7.2) contained 1.55 g/L KH2PO4, 4.95 g/L K2HPO4, 10 mM 
glycerol, 5 mM glucose, 5 mM succinate, trace elements (Rosenberger and Elsden, 
1960), and, 180 µM RDX as a sole nitrogen source or unless specified. 
2.2.2 Luria-Bertani Peptone (LBP) medium   
Complex medium (LBP) consisted of 1 % (w/v) Bacto-peptone, 0.5 % (w/v) yeast 
extract and 1 % (w/v) NaCl. 
2.2.3 Luria-Bertani (LB) medium   
Complex medium (LB) consisted of 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract and 1 
% (w/v) NaCl. 
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Table 2.1. List of primers used for amplification of DNA fragments.  
Name                                Sequence                                                                                        Target 
 
Primers for detection of xplA and xplB (Chapter 3 and 5) 
 
xplA-HindIIIF AAGCTTATGACCGACGTAACTGTC   xplA 
xplA-531F       GAACAACCCCTATCCCTGGT    xplA 
xplA-XbalR      TCTAGATCAGGACAGGACGATCGG   xplA 
xplA-1033R      TCAGATAGCCGAAAGCGACT    xplA 
xplB-KpnF1      GGTACCATGGACATCATGAGT   xplB 
xplB-614           AGTTCGACCCGGTGATGAT    xplB 
xplB-XbaR1290      TCTAGATCAGCAGACCGATTC   xplB   
xplB-1142R      ACTGTCCGGTCGATCACTTC    xplB  
 
Primers for qPCR (Chapter 4 and 5) 
                                                      
perm-F_RT852      GCCGCGACGACATGATC    permease  
perm-R_RT906      CGTTTGGCATCGAACTTCTTG   permease     
xplA-F_RT413                  CCGAGTGGGCCAAACAGT xplA 
xplA-R_RT468      TCCTCCTCGTCGAGTTCGAT    xplA 
gyrB-F_RT259  GCCGAGGAGCAGGAACAG    gyrB 
gyrB-R_RT323 TAGTGGTAGACGCGGGTCTTG   gyrB 
                                                               
Primers for cloning and expression (Chapter 4) 
 
Permease-F(Lic)              CCAGGGACCAGCAATGAGTCCGTGGGCGAACTTCG permease 
Permease-R(Lic)      GAGGAGAAGGCGCGCTACTCCCCGGTCTTCTTCGGAATCG permease 
PermF1+NcoI                   TCAAACCATGGATGAGTCCGTGGGCGA   permease 
Perm-R1371+NdeI GTTCGCATATGGTCGCTACTCCCCG   permease 
xplAf-1+RBS+NheI      CCGAGCTAGCGAGAAGGAGTGTGGAGAAT  xplA 
xplARend+HindIII      TCGGATAAGCTTTCAGGACAGGACGATCG  xplA 
 
 
Primers for mutagenic plasmids construction (Chapter 5)  
 
UpF822(perm)+EcoRI      ACGTCGGAATTCAGTGTCGGGCGGACC   permease upstream   
UpR30(perm)+NdeI      GAATTCCATATGGGACGTATAACCGAG   permease upstream          
DwnF0(perm)+NdeI      ATTCCGCATATGAAGAAGACCGGGGAG   permease downstream 
DwnR975(perm)+HindIII GCGCAGAAGCTTCCTGGGCAGATCGAC   permease downstream 
  
UpF861(rp)+EcoRI           GGGGAATTCCGAGGATCGCCGTGA   regulator upstream 
UpR75(rp)+NdeI               TGGTCCCATATGGCCCGACACTCGACG   regulator upstream 
DwnF116(rp)+NdeI      CTGGCGCATATGTCAAAAAACCCTAT   regulator downstream 
DwnR852(rp) +HindIII      ACAGACAAGCTTCGATCAGTGCGGCGG   regulator downstream 
 
UpF816(xplA)+EcoRI      CGATCTGAATTCGCACCCGGACACCCT   xplA upstream 
UpR33(xplA)+NdeI      ATTCTCCATATGGGGTTCACTGCAGGC   xplA upstream 
DwnF7(xplA)+NdeI      GTCCTGACATATGATCCGATCTCACCTGCC  xplA downstream                              
DwnR975(xplA)+HindIII CCCAAGCTTGACGGTCCAGGGCGTTGT   xplA downstream 
 
UpF1083(xplB)+EcoRI     ACCATGGAATTCACGAACATCAGAGCT   xplB upstream 
UpR135(xplB)+NdeI         GTCGAGCATATGCACGTCGGGGATACG   xplB upstream 
DwnF30(xplB)+NdeI    ACCCGACATATGACACCCGAGATGGAG   xplB downstream 
DwnR849(xplB)+HindIII   CGTCCAAAGCTTCCAGTTTCGGCGTGA   xplB downstream 
 
 
Primers for detection of sacB, permease, regulator and 16S (Chapter 4 and 5) 
 
sacBf 488       GGTCAGGTTCAGCCACATTT    sacB 
sacBr 1262       CCTTTCGCTTGAGGTACAGC    sacB 
permF260       TGATCGCGCTGCTCGTCACCAT   permease 
permR1086      CGAGGACGACCATCTGGAAGGCGAT   permease 
permease-1F          ATGAGTCCGTGGGCGAACTTCG   permease 
permease-1395R      CTACTCCCCGGTCTTCTTCGGAAT   permease      
rpF1       GTGACGAACGACGATCTGGTGCAC                   regulator 
rpR543       ACAATGGTCATGTTCCGGTAACC                                                regulator 
fD1       AGAGTTTGATCCTGGCTCAG                                                         16S 
rD2       AAGGAGGTGATCCAGCC                                                               16S 
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2.2.4 Tryptone medium  
Tryptone medium (pH 6.5) contained 2 % (w/v) tryptone, 1 % (w/v) NaCl and 1 % (w/v) 
of yeast extract. After autoclaving, following chemicals were added: 10 % (w/v) 
PEG3350, 5 % (v/v) DMSO and MgCl2 (0.2 M). 
2.2.5 RDX dispersion agar 
The RDX dispersion agar contained 1.5 % (w/v) of agarose with minimal medium as 
described previously (2.2.1) and 5 mM of RDX as nitrogen source.   
2.3 Bacterial strains and plasmids 
See Table 2.2 for details of bacterial strains used in this study.  
The plasmid pLIC-YSBLIC 3C (University of York) was used for both cloning and 
expression. The plasmid pK18mobsacB required for the gene deletion was kindly 
provided by Professor Eltis Lindsay (University of British Columbia, Canada).  
2.4 Growth and resting cell experiments 
2.4.1 Growth experiment and RDX degradation 
Microbial growth was monitored by measuring the OD600 using a UV-160A recording 
spectrophotometer (Shimadzu Corp., Kyoto, Japan). For RDX measurement, samples 
were taken from the cultures at intervals over the incubation time. Cells were pelleted 
by centrifugating at 15,000 x g for 3 minutes and the supernatant was used to measure 
RDX concentration by HPLC (2.7.1).  
2.4.2 Resting cell assays 
Cells (0.01 g/mL) were incubated in minimal medium contained RDX (100 µM) for 3 h. 
Samples were taken at different time points and 10 % of trichloroacetic acid (1.5 M) 
was added to stop the XplA activity. Samples were then centrifuged (15,000 x g) for 3 
minutes and the supernatant was used for RDX analysis measured by HPLC. 
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   Table 2.2. Bacterial strains used in this study. 
 
Bacterial strain  
 
Details  Source 
Rhodococcus 
rhodochrous strain 11Y 
RDX degrading bacteria  Seth-Smith et al., 
2002 
Rhodococcus 
erythropolis strain HS4 
RDX degrading bacteria  Seth-Smith et al., 
2008 
MarR (ORF 27) 
knockout strain 
Derived from 11Y using 
unmarked gene deletion 
system (van der Geize et al 
2001). 
In this study 
Permease (ORF 29) 
knockout strain 
Derived from 11Y using 
unmarked gene deletion 
system (van der Geize et al 
2001). 
In this study 
xplB knockout strain Derived from 11Y using 
unmarked gene deletion 
system (van der Geize et al 
2001). 
In this study 
xplA knockout strain Derived from 11Y using 
unmarked gene deletion 
system (van der Geize et al 
2001). 
In this study 
NovaBlue Singles General cloning strain  Novagen-Merck 
Rosetta 2 (DE3) 
 
Used for expression of genes 
containing rare codons. 
Rosetta 2 (DE3) contains 
pRARE2 plasmid encoding 
tRNA genes for the rare 
codons AUA (Ile), AGG (Arg), 
AGA (Arg), CGG (Arg), CCC 
(Pro), GGA (Gly) and CUA 
(Leu). 
Novagen-Merck 
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2.5 Protein techniques  
2.5.1 Preparation of cell free extracts 
Cells were resuspended in 40 mM potassium phosphate buffer (pH 7.2). 
Phenylmethylsulfonyl fluoride (PMSF 0.2 mM), a proteinase inhibitor, was added to 
cells prior to sonication (S-4000 Sonicator, Misonix). This was carried out by using a 
small probe operated at amplitude of 70 % for 3 s and 7 s cooling intervals for a total of 
4 min. All steps were performed in an ice-water bath. Centrifugation (14,000 x g) to 
separate soluble and insoluble fraction was performed (SS 34 rotor; High Speed 
Sorvall RC5B+ centrifuge). The supernatant was taken and used for cell free extract 
assays and western blot analysis. 
2.5.2 Protein quantification 
Total protein concentration was measured according to the protocol of the Coomassie 
(Bradford) Protein Assay Kit (Thermo Scientific Pierce). The protein assay standard 
curve was prepared using a series dilution of bovine serum albumin (BSA). Samples 
(10 µL) were mixed with 1000 µL Bradford reagent and read at the absorbance of 595 
nm. The protein concentration (C) is determined based on the following equation: “C = 
A/0.0012”, where A corresponds to the absorbance. 
2.5.3 SDS-PAGE gel analysis 
Proteins were analysed using a SDS-PAGE gel (0.75 mm, 12 %). The gel contains two 
layers (separating and stacking layer). The separating layer was made up by Tris-HCl 
(375 mM, pH 8.8), SDS (0.1 % w/v), acrylamide (12 % w/v), N,N-methylene-bis-
acrylamide (0.3 % w/v), TEMED (0.04 % v/v) and ammonium persulfate (0.1 % w/v). 
This layer was topped by a stacking layer, which the composition was the same as 
separating layer except for Tris-HCl (125 mM, pH 6.8),  acrylamide (5 % w/v) and N,N-
methylene-bis-acrylamide (0.1 % w/v). Samples were diluted (1:4) in loading buffer 
(SDS (2 % w/v), bromophenol blue (0.15 % w/v), Tris-HCl (60 mM, pH 6.8), glycerol 
(15 % v/v) and beta-mercaptoethanol (5 % v/v)) and heated at 100 °C for 5 min. The 
gels were run at 200 V for 50 min and stained with InstantBlue, a coomassie based 
staining solution (Expedeon, UK).  
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2.5.4 Western blot analysis  
XplA detection 
Initially, two gels were run and one of the gels was used for quantitative determination 
stained with InstantBlue. Another gel was used to develop the nitrocellulose 
membrane. This gel was first incubated in pre-chilled Towbin transfer buffer (25 mM 
Tris, 192 mM Glycin, 20 % (v/v) Methanol, pH 8.3) for approximately 15 minutes. 
Nitrocellulose membrane (Schleicher and Shuell BioScience, Protran BA 83, 
cellulosenitrate (E), 0.2 µM, 200 x 200 mm, Dassel Germany) and filter paper 
(Whatman, 3 mm chromatography paper) were cut according to gel size. The 
membrane was incubated in pre-chilled Towbin transfer buffer for 25 minutes. The filter 
paper was briefly soaked in the transfer buffer before the gel/membrane sandwich 
complex.  
To make the gel/membrane sandwich complex, three pieces of filter papers were 
placed onto the anode of the transfer unit, followed by the membrane, gel and another 
three pieces of pre-soaked filter paper. All steps were preformed carefully to avoid any 
bubbles forming within the layers. This was followed by placing the cathode onto the 
sandwich complex and a currency of 10 V was applied to allow the transfer for one 
hour. After the transfer of protein onto the membrane, the membrane was rinsed in 
TBS (Tris buffered saline 1x, 150 mM NaCl, 25 mM Tris-HCl, pH 7.5). The membrane 
was then blocked with 1x TBS containing 3 % (w/v) non-fat milk powder (Marvel) in the 
cold room overnight.  
The membrane was then incubated with primary antibody, XplA antibody (TBS 1x, 3 % 
(w/v) BSA, 10 µL antibody/10 mL) for one hour, after which, following treatments were 
carried out: incubation of membrane with TBS, 0.1 % Tween 20 (x2) for 5 minutes, 
then, with TBS, 0.5 % Tween 20, 1M NaCl (x2) for 5 minutes and briefly rinsed with 
TBS and TBS containing 3 % (w/v) of BSA. The membrane was incubated with 
secondary antibody, goat anti-rabbit conjugated to alkaline phosphatase, in a dilution of 
1/20000 for one hour, followed by several treatments: incubation with TBS, 0.1 % 
Tween 20 (x2) for 5 minutes, then, with TBS, 0.5 % Tween 20, 1M NaCl (x2) for 5 
minutes and briefly rinsed with TBS, 0.1 % Tween 20 and TBS. The membrane was 
then incubated in 10 mM Tris pH 9.6 for 5 minutes. The membrane was developed 
using Sigma tablets containing of active compound of nitroblue tetrazolium and 5-
bromo-4-chloro-3-indolyl phosphate dipotassium for approximately 10 minutes. The 
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reaction was stopped by washing the membrane with TBS, 0.1 % Tween 20, TBS and 
water.    
His-tag protein detection 
This western blot analysis was performed based on procedure described above with 
some modification. After the membrane was blocked with 1x TBS containing 3 % (w/v) 
of non-fat milk powder overnight, it was incubated with anti-polyhistidine conjugated to 
peroxidase, in a dilution of 1/2000 for two hours. The membrane was then developed 
using peroxidase substrate 4-chloro-1-naphthol. All steps were performed at room 
temperature. 
2.5.5 Specific activity of XplA in cell free extracts 
To determine the specific activity of XplA in the cell free extracts, activity assays were 
set up. The reaction contained cell free extracts (75 µL), NADPH (300 µM), Spinach 
ferredoxin reductase (Sigma) (0.1 U/mL) and RDX (100 µM) in a final volume of 150 
µL. All of the reactions were performed aerobically at room temperature (20 °C) and 
the NADPH oxidation rate was monitored at absorbance 340 nm. The difference in 
NADPH concentration after three min of reaction time was calculated using the 
following equation:  
                                             ∆C     K 
                                             ∆t       ε 
 
 
 
 
The specific activity of XplA in the cell free extracts was determined based on the 
following formula: 
      Specific activity = (rate of reaction [µmol/L/min] x volume of reaction [L])/ total protein [mg] 
∆C: difference in [NADPH]  
∆t: reaction time (n min) 
K: change of absorbance over reaction time 
ε: extinction coefficient of NADPH at 340 nm (6.2 x 10-3 µM-1 cm-1) 
= 
 59 
2.6 Molecular biology techniques  
2.6.1 Gel electrophoresis of DNA 
DNA fragments were separated by agarose gel electrophoresis using 1 % (w/v) 
agarose in Tris-acetate-EDTA buffer (40 mM Tris-HCI, 18 mM glacial acetic acid and 1 
mM ethylenediaminetetraacetic acid (EDTA)). The loading dye consisted of 0.15 % 
(w/v) bromophenol blue, 0.5 % (w/v) SDS, 0.15 M EDTA and 50 % (v/v) glycerol and 
was added to the sample to a final dilution of 20 % (v/v). DNA was visualised by adding 
10 µg mL-1 ethidium bromide to the gel and viewing under UV. Fragment size was 
determined by comparison to a 10 kb Smart Ladder (Eurogentec) or 1kb ladder (NEB) 
that had been run alongside the lanes of interest. 
2.6.2 Polymerase chain reaction (PCR) 
Polymerase chain reaction was carried out for screening and cloning purposes.   
For the screening purposes, GoTaq® DNA polymerase (Promega) was used, which 
contained 1x GoTaq buffer, 0.4 µM of dNTPs, 1.5 mM MgCl2, 0.4 µM of forward and 
reverse primers, 0.7 U GoTaq® DNA polymerase, 16 µL distilled H2O and 20-40 ng 
DNA template in a total volume of 25 µL.  
For cloning purposes, Phusion DNA polymerase (New England Biolabs) was used. 
Reactions of 50 µL consisted of 1x HF buffer, 2.5 mM of dNTPs, 0.4 µM of forward and 
reverse primers, 1 U Phusion DNA polymerase, 36 µL distilled H2O and 40-80 ng DNA 
template.  
PCR cycle started with an initial denaturation step of 95 °C for 5 minutes, followed by 
30 cycles of denaturation step of 95 °C (30 s), annealing step (varied temperature-
determined from primers melting temperature) and extension step of 72 °C (1-3 
minutes). A final extension cycle at 72 °C for 10 minutes was performed. 
The reaction was performed in a thermocycler (ThermoElectron Corp.). 
 60 
2.6.3 Digestion, dephosphorylation and ligation of DNA 
Restriction endonuclease digestion of DNA (inserts fragments or plasmid), 
dephosphorylation of the linearised plasmid and DNA ligation were performed 
according to the manufacturer’s protocol (NEB).  
2.6.4 Preparation of competent cells (calcium chloride method) 
E.coli (Novablue) was inoculated in LB (10 mL) and grown overnight at 37 °C. Then, 5 
mL of the pre-culture was inoculated into 450 mL of fresh LB medium and allowed to 
grow until OD600 reached between 0.4 and 0.5. Cells were harvested by centrifugation 
at 4 °C for 15 minutes (13,000 x g) and resuspended in 50 mL sterile ice-cold calcium 
chloride (100 mM). This was followed by another centrifugation at 4 °C for 15 minutes 
(6,600 x g) and resuspended in 50 mL sterile ice-cold calcium chloride (100 mM). The 
cells were incubated on ice for 1h and harvested by centrifugation at 4 °C for 15 
minutes (3,300 x g). Supernatant was decanted and cells were gently resuspended in 1 
mL of ice-cold sterile CaCl2 (100 mM). The competent cells were used immediately or 
ice-cold sterile glycerol was added to a final concentration of 15 % (v/v) for storage. 
Cells were aliquoted into 50 µL and stored at -80 °C.  
2.6.5 Preparation of competent cells (for knockout experiment) 
A pre-culture (5 mL) of E.coli (S17-1) in LB was incubated overnight at 37 °C. Then, 0.5 
mL of pre-culture was inoculated into 50 mL of pre-warmed medium and incubated at 
37 °C to allow OD600 reached between 0.3 and 0.4. This was followed by 3,000 x g 
centrifugation at 4 °C for 10 minutes and resuspended cells in 0.5 mL tryptone medium. 
Cells were aliquoted into 50 µL portions and stored at -80 °C for future use.  
2.6.6 Plasmid transformation (Heat shock) 
An aliquot (50 µL) of competent cells was thawed on ice. 2-3 µL of plasmid DNA, 
ligation reaction or LIC reaction was added into the cells. Cells were incubated on ice 
for 5 minutes and heat shocked at 42 °C (1 minute). Then, 3 minutes incubation was 
performed on ice. LB (500 µL) was added and cells were incubated at 37 °C for 1 hour. 
After the incubation, cell suspension was spread on a selective LB agar plate and was 
incubated at 37 °C overnight.  
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2.6.7 Quantitative real-time PCR (qPCR) analysis 
For RNA isolation, cell pellets were treated with RNAprotect Bacterial Reagent 
(Qiagen) to stabilise the total RNA in bacteria. Then, cells were incubated with 
lysozyme (80 mg/mL) and proteinase K (2 mg/mL) at 25 °C for 2 h with 150 rpm 
shaking. Glass beads (40 mg) were added into the cells suspension and cells were 
ruptured using a FastPrep machine (Q-biogene) at force 6.5 setting for 40 seconds. 
The total RNA isolation was performed using RNeasy Mini Kit (Qiagen) according the 
manufacturer’s instructions. The quantity and quality of total RNA was analyzed using 
NanoDrop spectrophotometer (Thermo Scientific).  
SuperScript II reverse transcriptase (Invitrogen) and random hexamer primers (Applied 
Biosystems) were used to reverse transcript total RNA (2 µg) into cDNA and the cDNA 
was then purified by Wizard PCR clean-up kit (Promega). The concentration of cDNA 
was determined using NanoDrop spectrophotometer. The qPCR reactions were 
performed in Applied Biosystems ABI7000 Real-time Quantitative PCR system. The 
SYBR Green PCR master mix contained 12.5 µL power SYBR green mix (Applied 
Biosystems), 5 µL cDNA (5 ng/µL), 2 µL primer pair mix (10 µM each primer) and 5.5 
µL nuclease free water. The cycle started with single step of 50 °C (2 min) and 95 °C 
(10 min), followed by 40 cycles of 95 °C (15 s) and 60 °C (1 min). The data was 
analysed by Applied Biosystems ABI7000 software with a DNA gyrase, subunit B 
(gyrB) as internal standard.  
2.6.8 Sequencing 
The DNA sequencing was performed by Technology Facility, University of York. 
Sequence analyses were performed by ClustalW and BLASTn.     
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2.7 Analytical techniques 
2.7.1 HPLC analysis 
The HPLC system used in this study contained a 510 pump, a Waters Alliance 2695 
separation module and a Waters 2996 Photodiode Array. Samples (50 µL) were 
separated using a Sunfire C18 5 µM column (Waters, Wexford, Ireland) at a flow of 1 
mL/min with the mobile solvent of 50:50 MeOH:H2O. The elution was monitored at 237 
nm and the RDX standard curve (Appendix B) was used to convert the peak area to 
the concentration of RDX in the samples.  
2.7.2 Griess assay 
Griess assay was used to measure nitrite content in samples. Samples (180 µL) were 
mixed with 50 µL of sulphanilamide (10 mg/mL sulphanilamide in 0.68 M hydrochloric 
acid) and 20 µL of N-(1-naphthyl)-ethylenediamine dihydrochloride (NED) (10 mg/mL 
NED in water). The reaction was incubated for two minutes at room temperature (20 
°C). The sample was measured at 540 nm and blanked against reagent. The 
concentration of nitrite was determined based on a standard curve of sodium nitrite 
(Appendix C).  
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Chapter 3 
RDX degradation in Rhodococcus 
erythropolis strain HS4 
3.1 Introduction 
Rhodococcus erythropolis strain HS4 is one of the nineteen strains of Rhodococcus 
capable of utilising RDX as a sole nitrogen source that was isolated from an RDX 
contaminated site (Seth-Smith, 2002). Strain HS4 was able to remove RDX supplied as 
a sole nitrogen source from growth medium, but was not able to utilise RDX supplied 
as a sole carbon and nitrogen source. When strain HS4 was grown on RDX dispersion 
agar, a clearance zone around the colony formed (Fig. 3.1), which was not observed in 
non-RDX degrading strains.  
 
 
 
 
 
 
 
Figure 3.1. Clearance zone formed by isolated RDX degrading bacteria of Rhodococcus 
strains on RDX dispersion agar (Seth-Smith, 2002). The clearance zone around strain HS4 
is clearly visible. 
 
 
HS4 
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It was demonstrated that RDX degradation activity in strain HS4 was inhibited by 
metyrapone, a cytochrome P450 inhibitor, suggesting that a cytochrome P450 system 
is involved in RDX degradation in this strain. The novel RDX degrading cytochrome 
P450 system XplA/B was first identified in Rhodococcus rhodochrous 11Y (Seth-Smith 
et al., 2002). Unlike the other 18 strains, Southern blot analysis suggested that the 
genes xplA and xplB were not present in HS4 (Seth-Smith et al., 2008). Furthermore, 
no DNA amplification products were detected using PCR with xplA and xplB specific 
primers on strain HS4 gDNA. These findings suggested that there might be a different 
P450 system responsible for biodegradation of RDX in strain HS4 and investigation of 
this is detailed in this chapter.   
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3.2 Materials and methods 
3.2.1 Assay development for RDX degrading activity 
To prepare the cell free extracts, cultures were grown in minimal medium (see Chapter 
2) with 200 µM of RDX. When cells reached late-log phase, they were centrifuged 
(14,000 x g), washed twice and resuspended to a concentration of 0.05 g wet weight/ 
mL in 40 mM of potassium phosphate buffer (pH 7.2). Phenylmethylsulfonyl fluoride 
(0.2 mM), a protease inhibitor, was added to cells prior to cells disruption.  
To detect RDX degrading activity in cell free extracts, reactions were incubated in 1 mL 
of minimal medium with 90 µM RDX at 20 °C; with or without addition of ferredoxin 
reductase (0.1 U/mL) and an cofactor recycling system that consisted of alcohol 
dehydrogenase (0.72 U/mL), NADPH (300 µM) and isopropanol (30 µL/mL). Samples 
were centrifuged (10,000 x g) for 2 minutes before sample analysis. Nitrite and RDX 
were measured using the Griess assay and HPLC, respectively (details for Griess 
assay and HPLC analysis, see Chapter 2). 
3.2.2 Protein purification using Protein A SpinTrap column 
Purification of an XplA-like from Rhodococcus erythropolis strain HS4 was performed 
using Protein A SpinTrap column according to the manufacturer’s instructions (GE 
Healthcare Life Sciences Company, UK). 
3.2.3 PCR amplification 
PCR amplification was carried out on DNA from strain HS4 for xplA and xplB using 
primers specific to these genes (see Chapter 2, Table 2.1). This was performed in a 
thermocycler (ThermoElectron Corp). The cycle started with an initial denaturation step 
of 94 °C 30 s, followed by an annealing step of 50 °C 30 s, an extension step of 72 °C 
1.5 min for 30 cycles and a final extension step at 72 °C for 10 min. 
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3.3 Results 
3.3.1 Whole cell assays of R. erythropolis HS4 
R. erythropolis strain HS4 were previously shown to be able to degrade RDX slowly 
(Seth-Smith, 2002). To test the RDX degradation activity in strain HS4, whole cell 
assays were performed along side strain 11Y (Fig. 3.2).       
 
 
 
 
 
 
 
 
Figure 3.2. RDX removal (%) by whole cells of strains HS4 and 11Y (0.05 g/mL) after 20 
hours of incubation at 20 °C. Initial RDX concentration was 100 µM. Error bars show one 
standard deviation for duplicate samples. 
 
Strain HS4 removed about 30 % of RDX after 20 hours of incubation, while all of the 
RDX was removed from the incubation mixtures by strain 11Y. The lower rates of RDX 
removal by HS4 was in agreement with previous observations described by Seth-Smith 
(Seth-Smith, 2002). Since whole cells of strain HS4 had less RDX activity compared to 
strain 11Y, cell free extracts of strain 11Y were used to develop an assay for the 
detection of XplA activity in cell free extracts. 
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3.3.2 Assay development to detect RDX degrading activity 
(XplA) in cell free extracts 
A previous study indicated that a cytochrome P450 system in both strains 11Y and 
HS4 was involved in RDX degradation (Seth-Smith, 2002); however, no RDX 
degrading activity in cell free extracts could be detected. More recent work on the 
characterisation of purified recombinant XplA revealed that the NADPH and reductase 
XplB were required for RDX degradation (Jackson et al., 2007). Also, active XplB was 
obtained as a GST fusion and the cleavage of the GST from the purified fusion protein 
caused precipitation suggesting XplB could be unstable in cell free extracts. It was 
found that a surrogate commercially supplied spinach leaf ferredoxin reductase can 
partner XplA for RDX activity (Edwards, 2006). These findings allowed the 
development of an assay for XplA activity in cell free extracts. 
In this assay, the cofactor recycling system and ferredoxin reductase were included to 
ensure the supply of reducing equivalents was not limiting the reaction. The cofactor 
recycling system consisted of alcohol dehydrogenase, NADPH and isopropanol. 
Activity was detected by measuring the release of nitrite (Griess assay, section 2.7.2) 
and reduction of RDX (HPLC, section 2.7.1). The reactions of sulphanilamide and NED 
with nitrite (RDX breakdown product) forms a colour compound in the Griess assays, 
which can be measured at 540 nm.  Whole cells of strain 11Y were used as a positive 
control. Boiled cell free extracts with ferredoxin reductase was the negative control and 
results are shown in Figures 3.3 and 3.4.  
In the presence of ferredoxin reductase, in combination with a cofactor recycling 
system, 56 % of the 90 µM RDX was degraded with the production of 96 µM of nitrite 
over the incubation time of 90 min (Fig. 3.3b and Fig. 3.4). The addition of the cofactor 
recycling system-only in the absence of ferredoxin reductase showed approximately 11 
% of the RDX had been degraded (Fig. 3.3c and Fig. 3.4). However, no 
biotransformation of RDX occurred in the absence of ferredoxin reductase and cofactor 
recycling system, suggesting parts of the reductase(s) in strain 11Y had lost activity 
after the cells were disrupted, and that NADPH plays an important role in RDX 
biodegradation. No RDX reduction was observed in the negative control containing 
boiled of both cell free extracts of 11Y and ferredoxin reductase, demonstrating that 
XplA in cell free extracts in combination with ferredoxin reductase were responsible for 
the RDX activity. In the positive control, all of the RDX was degraded after 90 min of 
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incubation (Fig. 3.4). Only low levels of nitrite were detected in 11Y whole cells and it is 
likely that this product was assimilated by the cells during the incubation period.  
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Figure 3.3. RDX activity in cell free extracts of strain 11Y under aerobic condition after 90 
minutes of incubation. (a) Cell free extracts only (without addition of ferredoxin reductase and 
a cofactor recycling system). (b) Cell free extracts with addition of ferredoxin reductase and a 
cofactor recycling system. (c) Cell free extracts without addition of ferredoxin reductase. (d) 
Negative control (*boiled ferredoxin reductase and cell free extracts). (e) Positive control (whole 
cells of strain 11Y). The initial RDX concentration for all reactions was 90 µM. 
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Figure 3.4. RDX (grey) and nitrite (white) concentration after 90 minutes of incubation 
with cell free extracts of 11Y under aerobic conditions at 20 °C. Error bars show one 
standard deviation for triplicate samples. 
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3.3.3 RDX activity in cell free extracts of strain HS4 
Following the development of an assay to detect RDX degradation in cell free extracts 
of 11Y, the assay was used to measure RDX degradation in cell free extracts of strain 
HS4, with strain 11Y used as a positive control. The results (Figure 3.5) showed that 
whilst RDX was degraded in extracts of strain 11Y, with the production of nitrite, no 
RDX degrading activity was observed in cell free extracts of strain HS4 despite the 
addition of ferredoxin reductase and a cofactor recycling system. No RDX degrading 
activity was detected in the negative controls by HPLC analysis and Griess assays. 
Whole cells of strain HS4 removed approximately 30 µM RDX during the 20 h of 
incubation time.  
 
Figure 3.5. Analysis of HS4 cell free extracts for RDX degradation after 20 h at 20 °C 
under aerobic conditions. Grey and white bars represent RDX and nitrite concentration 
respectively. Error bars show one standard deviation from triplicate samples. 
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3.3.4 Western blot analysis of strain HS4 cell free extracts  
An antibody to the recombinant, purified XplA cloned originally from 11Y was used to 
investigate whether protein(s) in strain HS4 cell free extracts had cross-reactivity to 
anti-XplA antibodies. Extracts were run on gels for quantitative determination of protein 
following staining with InstantBlue (data not shown), and, using semi dry transfer onto 
nitrocellulose membrane, for western blotting (Fig. 3.6).  
The primary (XplA) and secondary (goat anti-rabbit antibody conjugated to alkaline 
phosphatase) antibody incubations were followed by membrane development. A band 
with a molecular weight of ~58 kDa was detected from strain HS4 cell free extracts, a 
smaller molecular weight than XplA (70 kDa). The band was not clearly visible on the 
Coomassie-stained gel, so peptide sequencing was not performed at this stage. Given 
the apparent cross-reactivity of the XplA antibody with HS4, affinity purification of the 
HS4 protein of interest was attempted. 
 
 
 
 
 
 
 
 
 
Figure 3.6. Western blot analysis of cell free extracts of strains 11Y and HS4. (M); Protein 
marker, (1); Purified recombinant-XplA (0.33 mg/mL), (2); Cell free extracts of strain 11Y (total 
protein of 1.9 mg/mL), (3); Cell free extracts of strain HS4 (total protein of 1.0 mg/mL).  
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3.3.5 Purification trial of a putative RDX degrading enzyme in 
strain HS4  
Protein A HP SpinTrap columns (GE Healthcare) are a simple and small-scale antibody 
purification columns. The Protein A Sepharose HP has a high affinity for the Fc region 
of IgGs antibodies. The XplA antibody is an IgG type antibody and thus this column 
was chosen for protein purification. To start with, XplA antibodies were bound 
covalently to Protein A Sepharose High Performance matrix by using the cross-linking 
agent dimethyl pimelimidate dihydrochloride in triethanolamine at pH 8.9. The unbound 
antibodies were removed before adding HS4 cell free extracts into the column. Elution 
was carried out after several washing steps. The eluates were analysed using SDS-
PAGE. The general principle for purification of proteins using antibodies is shown in 
Figure 3.7.  
 
 
 
 
Figure 3.7. Principle of purification of protein using XplA antibody.   
 
The primary antibody that was used for the western blot (Fig. 3.6) was from crude 
rabbit serum. This means that besides polyclonal XplA IgGs, there are other proteins in 
the serum. The rabbit serum was purified using Protein A to remove contaminants and 
to enable determination of the size of IgGs in the serum. This information is important 
as there is a possibility that the IgGs are of a similar molecular weight to the target 
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protein in HS4. To purify XplA IgG, a Protein A HP SpinTrap column was equilibrated 
with binding buffer (0.5 M Tris, 1.5 M NaCl, pH 7.5) then rabbit serum added. End-over-
end mixing for 30 minutes was carried out, then the protein eluted. The results are 
shown in Figure 3.8.    
 
 
 
 
 
 
 
 
Figure 3.8. Purification of IgGs in rabbit serum using Protein A HP SpinTrap column. (M) 
Protein marker (B) rabbit serum before purification (C) excess antibody after binding to the 
column (W1-W3) washing steps before elution of binding IgGs (E1-E3) elution of IgGs using 
elution buffer (2.5 % of acetic acid).   
Elution of a single band from the Protein A column suggests that IgGs were 
successfully purified from rabbit serum and these had an apparent molecular weight of 
approximately 47 kDa (Fig. 3.8; E1-E2). The molecular weight of the IgGs is quite close 
to that of the protein of interest, about 58 kDa (Fig. 3.6); however, cross-linking of the 
Protein A column with XplA antibody prior to the purification of the protein from HS4 
cell free extracts should remove the IgG from subsequent SDS-PAGE analysis. A 
single band at the elution step confirmed that the column was working well for 
purification and so purification of the protein of interest from strain HS4 was then 
carried out.  
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To minimise impurities that may bind to the column and then co-elute with the target 
protein during the purification, cell free extracts were pre-cleared with a SpinTrap 
column that had not been coupled with any antibody as suggested by the manufacture. 
HS4 cell free extracts were incubated for four hours on the column before collection of 
the cleared cell free extracts, as suggested by the manufacture, and these cell free 
extracts were then used for purification.   
 
 
 
 
 
 
 
 
 
Figure 3.9. Purification of protein from HS4 that is active towards XplA antibody (M) 
Protein marker (E1-E3) elution of target protein using elution buffer (0.1 M Glycine-HCl, pH 2.9) 
(C) HS4 cell free extracts.   
The elution steps in the protein purification show a band at molecular weight about 47 
kDa instead of 58 kDa (Fig. 3.9). This means that the eluate most probably contains 
IgGs of XplA antibody, not the protein of interest from strain HS4. To investigate this 
further, the experiment was repeated using cell free extracts of strain 11Y to purify 
XplA, as a positive control system. Following application of strain 11Y cell free extracts 
to the column and washing steps, no XplA was detected in the elution fraction (Fig. 
3.10a). To investigate where XplA was ‘lost’ during the process, western blot analysis 
was carried out on the column factions (Fig. 3.10b).  
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Figure 3.10. SDS-PAGE (a) and western blot (b) following purification of XplA from 11Y 
cell free extracts. (M) Protein marker (C) 11Y cell free extracts (F) flow through (W1-W2) 
Washing steps before elution (E1-E3) elution of target protein using elution buffer (0.1 M 
Glycine-HCl, pH 2.9).  
Western blot analysis showed that most of the XplA was present in the flow through.  
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3.3.6 Lost of RDX activity in new batches of strain HS4  
Additional experiments were performed to try to improve the cross-linking of the XplA 
antibody to the column, this used the remaining original cell free extracts of strains 11Y 
and HS4 and new batches of strains HS4 and 11Y cell free extracts were prepared. It 
is unfortunate that the new batches of whole cell of HS4 from the original glycerol stock 
cultures did not show RDX activity despite the incubation time continued until a month 
(data not shown).  
3.3.7 Zone of clearance on RDX dispersion agar 
Strain HS4 has previously been shown to be able to form a zone of clearance on RDX 
dispersion agar (Seth-Smith, 2002), and it was this preliminary observation that 
suggested this strain was able to degrade RDX. This screen was repeated using the 
latest batch of strain HS4 and no zone of clearance was observed after four weeks of 
incubation time (Fig. 3.11). This confirmed strain HS4 had lost its activity towards RDX.  
 
 
 
 
 
 
 
 
 
Figure 3.11. RDX dispersion agar for strains 11Y and HS4. No zone of clearance was 
observed in the latest RDX dispersion agar for strain HS4. 
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It was possible that the HS4 cells in the glycerol stock were a mixed population, or one 
that had somehow lost the ability to degrade RDX. To try to recover a line of strain HS4 
that still has the ability to degrade RDX, the glycerol stock of strain HS4 was spread on 
RDX dispersion plates supplemented with 100 µM of ammonium chloride to enhance 
the growth of the strain. None of the colonies produced a zone of clearance on the 
RDX dispersion plate after one month of incubation (Fig. 3.12). Incubation time was 
prolonged to four months and still no zones of clearance were observed.  
 
 
 
 
 
 
 
Figure 3.12. Growth of strain HS4 from glycerol stock on RDX (5 mM) dispersion agar. No 
zone of clearance was observed in the any of the colonies that grew on the RDX dispersion 
plate supplemented with 100 µM of ammonium chloride. 
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3.3.8 PCR amplification of xplA and xplB homologue  
To look for the xplA/B genes in strain HS4, colony PCR amplification for xplA and xplB 
using different combination of primers was carried out (details for primers, see Chapter 
2).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13. PCR amplification using primers specific to xplA and xplB genes with 
different primers combination (a) xplA-HindIIIF + xplA-XbalR; (b) xplA-HindIIIF + xplA-1033R; 
(c) xplA-531F + xplA-1033R; (d) xplA-531F + xplA-XbalR; (e) xplB-KpnF1 + xplB-XbaR1290; (f) 
xplB-KpnF1 + xplB 1142R; (g) xplB-614F + xplB 1142R; (h) xplB-614F + xplB-Xbar 1290. 
  
  
Colony PCR showed that a product of the expected size using different combinations of 
primers was amplified in strain 11Y. However, no PCR product was amplified from 
strain HS4.  
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3.3.9 Sequencing of 16S rRNA gene in latest Rhodococcus 
erythropolis strain HS4 
To confirm whether the bacterium used in these studies is the Rhodococcus 
erythropolis strain HS4 and not a contaminant, 16S rRNA was amplified using universal 
primers. The sequence showed 99 % sequence identity with the Rhodococcus strain 
HS4 amplified by Dr Seth-Smith (data not shown).  
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3.4 Discussion  
Rhodococcus erythropolis strain HS4 had previously been shown to be capable of 
degrading RDX and its activity inhibited was by metyrapone, a P450 inhibitor, 
suggesting that the enzyme involved in RDX degradation in this strain is a cytochrome 
P450 (Seth-Smith, 2002). Generally, the mechanism of a cytochrome P450 system 
involves the transfer of electrons from NAD(P)H to a reductase redox partner and the 
electron further transferred to the heme catalytic centre of the P450 enzyme to activate 
the enzyme. Therefore, ferredoxin reductase (a general surrogate partner for P450 
enzymes) and cofactor recycling system were included in the assay development to 
detect RDX degrading activity in cell free extracts.  
Incubation of cell free extracts of strain 11Y with ferredoxin reductase and the cofactor 
recycling system gave the highest RDX degrading activity (56 %). Lower RDX activity 
(11 %) was observed when cell free extracts were incubated with the cofactor recycling 
system in the absence of the ferredoxin reductase. Results clearly indicate that the 
P450 redox partner plays an important role in RDX biodegradation. No activity was 
shown in cell free extracts when the ferredoxin reductase and cofactor recycling 
system were absent in the reaction mixture. This shows that XplB might have lost 
significant activity throughout the cells disruption process. Enzymes are often 
degradation-sensitive molecules when released from their protected environment. As 
soon as cells are disrupted, pH fluctuations occur and enzyme-damaging activities 
such as proteases and free radicals are released. This could explain why whole cells of 
strain 11Y showed higher RDX activity than cell free extracts and perhaps why the 
addition of a reductase and cofactor recycling system was a crucial step to amplify the 
XplA activity in cell free extracts. 
While initial experiments showed that whole cells of strain HS4 showed very low RDX 
degrading activity (30 µM RDX degraded after 20 h of incubation), there was no activity 
observed when cell free extracts of the strain were incubated in various conditions as 
described in section 3.3.3. Despite the addition of a reductase and an cofactor 
recycling system, RDX degrading activity in cell free extracts could not be detected. 
This is perhaps not surprising as rates of RDX removal by whole cells of strain HS4 
were low; 11Y showed reduced rates of RDX degrading activity in cell free extracts 
compared with whole cells and the enzyme(s) responsible for activity in HS4 strain 
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might have additionally been even more susceptible than 11Y to damage as a result of 
the cell disruption process.  
Given that cell free extracts from the first incubations performed using HS4 had cross-
reactivity with the XplA antibody, as shown by western blot analysis (section 3.3.4), 
affinity purification of the enzyme that is responsible for RDX activity in this strain was 
performed. Experimental development confirmed that the XplA IgGs were successfully 
purified from the serum and that most of the contaminants were removed in the 
washing step, suggesting the column was working well. However, when purification of 
the 58 kDa HS4 protein, which had cross-reactivity with XplA antibody, was performed, 
only a single band with a MW of 47 kDa was present in the elution fractions.  
Since the XplA antibody in crude rabbit serum was developed using recombinant, 
purified XplA cloned from strain 11Y, this strain was used to optimise the affinity 
purification. However, attempts to purify XplA from cell free extracts of strain 11Y 
revealed that most of the XplA was present in the flow through (Fig. 3.10b). In 
conclusion, it is likely that the cross-linking of XplA antibody to the column failed. Given 
that subsequent experiments showed that strain HS4 had lost its activity toward RDX, 
optimisation of the cross-linking conditions was not further performed.  
It was unfortunate that the most recent incubations of Rhodococcus strain HS4 from 
the original glycerol stock made by Dr. Seth-Smith in 2000 did not show activity toward 
RDX despite the application of a range of approaches. It is worth noting that strain HS4 
was isolated about ten years ago and maintained in non-selective LB medium in the 
glycerol stock. Although unlikely, perhaps long term storage of strain HS4 in the non-
selective rich medium and multiple freezing and thawing of the stock culture could have 
caused this strain to lose its ability to degrade RDX. Naphthalene-degrading bacteria 
were reported to lose their activity towards naphthalene after being repeatedly 
transferred to fresh LB medium for several months (Stuart-Keil et al., 1998). An E. coli 
carried plasmid was stabilised under selective conditions and was easily lost when the 
bacterium was grown under non-selective conditions (Maschke et al., 1992). While 
bacteria grown without selective pressure can lose degradation activity toward their 
substrate over generations, both the studies of Stuart-Keil et al., (1998) and Maschke 
et al., (1992) were performed at temperatures where generation times must have been 
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orders of magnitude higher. It would be surprising if this was how the RDX degrading 
activity in strain HS4 was lost. 
In summary, the most recent incubations from glycerol stocks of Rhodococcus strain 
HS4 show no degradative activity toward RDX in whole cells, or cell free extract 
assays, and no band was detected in western blot analysis using cell free extracts from 
these incubations in the latest HS4 strain. Western blot analysis using cell free extracts 
of CW25, a non RDX degrader however, revealed a 58 kDa band (data not shown). 
This indicates that the 58 kDa band that was observed in previous HS4 cell free 
extracts is probably an artefact. Despite using a range of PCR techniques, no xplA/B 
products were amplified from strain HS4 DNA. Together these results show that this 
strain had lost RDX degrading ability, possibly encoded on a similar plasmid to that 
known to contain xplA/B in other strains of rhodococci. It was thus decided not to 
continue investigating this strain.   
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Chapter 4 
Heterologous expression of a 
putative permease from R. 
rhodochrous strain 11Y 
4.1 Introduction  
The flavodoxin-fused cytochrome P450 (XplA) and a reductase partner (XplB) were 
identified as responsible for RDX degradation in Rhodococcus rhodochrous strain 11Y 
(Seth-Smith et al., 2002). Chromosome walking upstream of the genes xplA and xplB 
in the genome of R. rhodochrous strain 11Y revealed the presence of an open reading 
frame encoding a putative permease, which is 100 % identical to a putative transporter 
in the RDX degrader Microbacterium sp. MA1 from North America (Chapter 1). 
Sequence analysis using membrane protein topology prediction software showed this 
putative transporter contained twelve predicted transmembrane domains (Fig. 4.1).  
 
Figure 4.1. Topology of the putative rhodococcal permease. Prediction of transmembrane 
helices in the permease was carried out by using TMHMM algorithm 
(http://www.cbs.dtu.dk/services/TMHMM/).   
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Heterologous expression and functional characterisation of membrane proteins in E. 
coli have been well documented (Miroux and Walker, 1996, Masi et al., 2003, Drew et 
al., 2006, Beckham et al., 2010). Zolotarev and co-workers (2008) reported that 
heterologous expression of a permease in E. coli increased uptake of sulphate and 
confirmed the permease as a sulphate transporter. It is often found that genes located 
close to each other are likely to have related function in biosynthetic or biodegradation 
pathways (Williamson et al., 2006, Yu et al., 2007). To investigate the involvement of 
the putative permease as an RDX transporter in strain 11Y, the rhodococcal putative 
permease in E. coli was expressed heterologously. This chapter describes the 
heterologous expression and characterisation of the putative permease from R. 
rhodochrous 11Y. 
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4.2 Materials and methods 
4.2.1 Ligation dependent cloning 
The permease and xplA were cloned individually and together in E. coli NovaBlue 
Singles using the vector pET-YSBLIC3C (kindly donated by the Technology Facility at 
the University of York).  
For plasmid preparation, pET-YSBLIC3C was digested in a total volume of 60 µL 
containing 6 µg pET-YSBLIC3C, 0.6 µL BSA (10 mg/mL), 5 U of restriction enzymes 
using either ‘NcoI and NdeI’ or ‘NheI and HindIII’ and 1x multi-core buffer (Promega). 
Reactions were incubated at 37 °C for 3 h, separated on an agarose gel (1 % w/v) and 
purified using a QIAquick gel extraction kit (Qiagen). The digested plasmid was 
dephosphorylated using 5 U of phosphatase per µg of DNA before ligation. 
The xplA gene was amplified using primers (Chapter 2) adapted with NheI and HindIII 
restriction sites. Similarly, the permease was amplified using primers (Chapter 2) 
creating PCR products with NcoI and NdeI restriction sites. The annealing temperature 
for all reactions was 63 °C with 1.30 minutes extension time at 72 °C for 30 cycles. The 
product sizes of xplA (1660 bp) and permease (1395 bp) were confirmed by gel 
electrophoresis. The PCR products were purified using Wizard PCR clean-up kit 
(Promega) and the DNA concentration was determined using NanoDrop UV-
spectrophotometer (Thermo Scientific). 
In order to create sticky ends for the ligation, the PCR products were digested by 
mixing 3 µg of PCR products, 1x multi-core buffer (Promega), 0.6 µL of BSA (10 
mg/mL), 5 U of NheI and HindIII (for xplA insert) or 5 U of NcoI and NdeI (for permease 
insert) in a total volume of 60 µL.  
The ligation reaction consisted of 3 molar inserts to 1 molar plasmid, 0.4 µL T4 ligase 
(Promega), 1x ligation buffer in a total volume of 20 µL. The reaction was incubated at 
16 °C overnight. Control of the ligation was the reaction without insert. Competent cells 
of E. coli NovaBlue Singles were transformed with 2 µL of the ligation reaction, spread 
onto LB agar and grown overnight at 37 °C. The presence of the permease and xplA 
inserts in pET-YSBLIC3C was confirmed by colony PCR using primers specific to 
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target genes (Chapter 2). Ligated constructs were transformed into Rosetta 2 (DE3) for 
gene expression studies.  
4.2.2 Ligation independent cloning (LIC) 
The ligation independent cloning technique was employed to clone and express the 
His-tagged rhodococcal permease (Bonsor et al., 2006).  
Plasmid 
The plasmid pET-YSBLIC3C was linearised in 1 mL of restriction enzyme reaction 
containing 5 µg of the pET-YSBLIC3C, 20 U BseRI and 1x buffer 2 (NEB) and was 
incubated at 37 °C for 1 h 50 min. The reaction mixture was separated on an agarose 
gel (1 % w/v) and the linearised plasmid was purified using a QIAquick gel extraction kit 
(Qiagen).  
 
To produce single stranded T-overhangs on the linerised plasmid, a T4 polymerase 
reaction was conducted. The reaction consisted of 4.0 pmol of linearised plasmid, 1x 
T4 polymerase buffer, 20 U of T4 polymerase (Novagen), 2.5 mM dTTP, 5 mM DTT 
and water to final volume of 400 µL. The reaction was incubated at 22 °C for 30 min 
then at 75 °C for 20 min. The plasmid was then purified using QIAquick PCR 
purification kit (Qiagen). The concentration of plasmid determined using NanoDrop UV-
spectrophotometer and stored at -20 °C. 
Insert  
The insert was generated using primers with LIC specific ends. The PCR reaction 
contained 1 µL of DNA, 0.4 µM forward primer (Forward: CCAGGGACCAGCA), 0.4 µM 
reverse primer (reverse: GAGGAGAAGGCGCG), 0.5 µL of dNTPs (25 mM), 1x of HF 
buffer (Finnzymes, UK), 1 U of Phusion polymerase (Finnzymes, UK) and water to 50 
µL. The PCR cycle started with an initial denaturation step of 96 °C for 30 s, followed 
by an anneal step of 61 °C for 30 s, an extension step of 72 °C 1.5 min for 30 cycles 
and a final extension step at 72 °C for 10 min. PCR product were cleaned using 
QIAquick PCR purification kit. 
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To produce single stranded A-overhangs, the insert reaction was carried out. The 
reaction contained 0.2 pmol of the insert, 2 µL T4 polymerase buffer, 2.5 mM dATP, 1 
µL dithiothreitol (100 mM), 0.4 µL T4 polymerase and water in a total volume of 20 µL. 
The reaction was incubated at 22 °C for 30 min and stopped by incubation at 75 °C for 
20 min.  
LIC reaction 
Two µL insert reaction was added to one µL of pET-YSBLIC3C vector (50 ng/µL) and 
the mixture was incubated for 10 minutes at 22 °C. One µL EDTA (25 mM) was added 
to the reaction mixture for ligation. The reaction was left at room temperature for 10 
minutes. Competent cells of E. coli NovaBlue Singles were transformed with 2 µL of 
LIC reaction and grown on LB agar contained kanamycin (100 µg/mL) to select for 
clones containing the plasmid with the insert. For expression studies, constructs were 
transformed into Rosetta 2 (DE3). Details for transformation see Chapter 2. 
4.2.3 XplA and permease expression  
Cells expressing XplA or the permease, or both XplA and the permease were grown in 
LB medium supplemented with kanamycin (100 µg/mL) and chloramphenicol (34 
µg/mL). As negative control, Rosetta 2 cells containing the empty vector were grown 
alongside. After overnight incubation at 37 °C with 250 rpm shaking, cells were cooled 
down to 20 °C, induced with IPTG (1 mM). Aminolevulinic acid (1 mM) and FeCl3 (0.5 
mM) were also added. Cells were then incubated at 20 °C for 17 hours and harvested 
and washed twice with 40 mM potassium phosphate buffer (pH 7.2).  
4.2.4 His-tagged permease expression 
LB medium (50 mL) containing 100 µg/mL kanamycin and 34 µg/mL chloramphenicol 
was inoculated with 0.5 mL of an overnight culture. The cultures were grown to an 
OD600 of 0.5 at 37 °C and IPTG (1 mM) was added. Cultures were left grown for 
another 3 or 18 h at 25 °C and cells were harvested by centrifugation at 14,000 x g 
(SS34 rotor, High Speed Sorvall RC5B+). 
4.2.5 Preparation of total protein fraction 
Total protein solubilisation buffer contained 1 % (w/v) SDS, 2M urea, 1.25 % (v/v) 2-
mercaptoethanol, 2.5 % (v/v) glycerol and 15 mM Tris (pH 6.8). A 200 µL aliquot of 
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protein solubilisation buffer was added into cell pellet (~10 mg). Samples were 
incubated at 100 °C for 15 min prior to SDS-PAGE and western blot analysis.  
4.2.6 Membrane protein isolation 
Cell pellets were resuspended with buffer containing 50 mM potassium phosphate 
buffer, 10 % (v/v) glycerol, 10 mM MgSO4 and 0.1 mg/mL DNase. Sonication was 
performed using the S-4000 Sonicator (Misonix) operated at an amplitude of 70 % with 
3 s and 7 s cooling intervals for a total of 4 min. All steps were performed in an ice-
water bath. Unbroken cells and cells debris were removed by centrifugation at 14,000 x 
g (SS34 rotor, High Speed Sorvall RC5B+) for 20 minutes at 4 °C. The supernatant 
was then centrifuged at 200,000 x g for 30 min in an ultracentrifuge (TLA100.3 rotor, 
Beckman Coulter). The pellets containing total membrane proteins were resuspended 
in 50 mM potassium phosphate buffer. The membrane fractions were snap-frozen in 
liquid nitrogen and stored at -80 °C.  
4.2.7 Permease purification 
This method was adapted from Mulligan (2008). 
 
Solubilisation reaction 
Membrane protein fractions were resuspended in solubilisation buffer consisting of 50 
mM potassium phosphate (pH 7.8), 20 % (v/v) glycerol, 200 mM NaCl, 0.5 % (w/v) of n-
dodecyl-β,D-maltoside (DDM) and 10 mM imidazole. The solubilisation reaction was 
incubated on ice for 30 min. Insoluble components were removed by centrifugation at 
200,000 x g (TLA100.3 rotor, Beckman Coulter) for 20 min at 4 °C. After centrifugation, 
the supernatant fraction that contained the soluble membrane proteins was used for 
permease purification.  
 
Ni2+ affinity chromatography 
The soluble membrane fraction was incubated in equilibrated Ni2+-NTA superflow resin 
(Qiagen, 0.1 mL/10 mg protein) for 1.5 hours in a disposable polystyrene column 
(Pierce). Unspecific bound proteins were removed by washing the column with buffer 
containing 50 mM potassium phosphate (pH 7.8), 20 % (v/v) glycerol, 200 mM NaCl, 
0.05 % (w/v) of DDM and 20 mM imidazole. Proteins bound with the resin were eluted 
with elution buffer that consisted 50 mM potassium phosphate (pH 7.8), 20 % (v/v) 
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glycerol, 200 mM NaCl, 0.05 % (w/v) of DDM and 500 mM imidazole. Fractions of 
purification were analysed on SDS-PAGE gel electrophoresis.  
4.2.8 RDX uptake assay 
Induced cells were washed twice with potassium phosphate buffer (pH 7.2) and 
suspended in potassium phosphate buffer (pH 7.2) at a concentration of 0.05 g/mL or 
0.25 g/mL. RDX (5 µM or 80 µM) was added into 500 µL of cell suspension and the 
assays were carried out under continuous stirring using a magnetic stirrer (size of 
magnetic stir bar is 0.5 cm). Samples were taken at different time points for 
measurement of the RDX concentration using HPLC. 
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4.3 Results 
4.3.1 Sequence analysis of the putative permease from R. 
rhodochrous 11Y 
Protein sequence of the 11Y putative permease was analysed using the Basic Local 
Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The 11Y permease was 
found to share 100 % amino acid identity with the Microbacterium sp. MA1 permease. 
The Mycobacterium vanbaalenii PYR-1 amino acid permease shared 72 % amino acid 
identity and other transporters (Table 4.1) shared more than 67 % sequence identity 
with the 11Y permease. A conserved domain of a transmembrane amino acid 
transporter protein was also found to be located in the amino acid sequence of 11Y 
permease.    
 
Table 4.1. Selected 11Y putative permease homologues with highest sequence 
identity.  
Accession Description Gene 
(bp) 
Protein 
(aa) 
Protein sequence 
identity (%) 
ACO88871.1 permease protein 
[Microbacterium sp. MA1] 
 
1395 464 100 
YP_952672.1 amino acid permease-
associated protein 
[Mycobacterium vanbaalenii 
PYR-1] 
 
1518 505 72 
YP_890909.1 amino acid permease 
[Mycobacterium smegmatis 
str. MC2 155] 
 
1497 498 70 
ZP_04686854.1 amino acid permease 
[Streptomyces ghanaensis 
ATCC 14672] 
 
1542 513 68 
YP_003652340.1 amino acid permease-
associated protein 
[Thermobispora bispora  
DSM 43833] 
 
1521 506 68 
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4.3.2 Permease and xplA expression in strain 11Y 
Genes which are under the control of a specific regulation system may exhibit a similar 
expression pattern when exposed to certain conditions. To investigate whether the 
expression of the permease has a similar expression pattern to xplA in strain 11Y, 
quantitative real time PCR (qPCR) was performed. This was done in the presence and 
absence of RDX as it is thought it may have an inducing effect on these genes. 
The results of the qPCR analysis showed when cells of strain 11Y were grown in 750 
µM of NH4Cl with or without RDX, both the xplA and permease were expressed. 
Interestingly, when RDX was supplied as a sole nitrogen source, transcription of xplA 
and permease was 16-fold and 27-fold respectively, higher than when cells were grown 
in the absence of RDX (Fig. 4.2). The similar expression patterns of the permease and 
xplA in strain 11Y under the different conditions tested indicates that both genes are 
regulated by a similar mechanism.  
 
 
Figure 4.2. Quantitative real time PCR analysis for xplA and permease in strain 11Y with 
gyrB as an endogenous control. The relative RNA expression of xplA and permease when 
cells were grown in different nitrogen sources: RDX (grey bar), RDX + NH4Cl (white bars) and 
NH4Cl (vertical bars). The gyrB was used to normalise data. Error bars show one standard 
deviation for triplicate samples.   
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4.3.3 PCR of permease homologue  
To examine whether the permease homologue is only present in the RDX degrading 
bacteria or if it is also found in related non-RDX degrading bacteria, colony PCR 
amplification using primers specific to the permease was performed. A total of thirteen 
RDX degrading bacteria that were available in our laboratory were chosen. Two 
Rhodococcus strains CW 25 and Rhodococcus strains 717, and E. coli (Rosetta 2) 
were used as examples of three non-RDX degrading bacteria.   
 
 
 
 
 
 
   
 
 
 
Figure 4.3. PCR amplification using primers specific to permease. (a) RDX degrading 
bacteria (Rhodococcus NCB 147-159); (b) Non-RDX degrading bacteria (Rhodococcus strain 
CW25, Rhodococcus strain 717 and E. coli Rosetta 2); (c) PCR amplification of 16S rRNA using 
universal primers confirmed template DNA from Rhodococcus strain CW25, Rhodococcus strain 
717 and E. coli Rosetta 2 were of good quality for PCR amplification. 
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The PCR analysis showed (Figure 4.3) that all of the thirteen RDX degrading strains of 
Rhodococcus spp. carry the permease gene and no PCR product was been observed 
in the non-RDX degraders.  
4.3.4 Cloning and expression of permease and XplA 
As described in Section 4.3.2, permease and xplA were significantly upregulated when 
cells of R. rhodochrous 11Y were grown with RDX as the sole source of nitrogen. This 
upregulation might reflect the involvement of the permease in RDX transport. To test 
this, the permease was expressed in E. coli Rosetta 2 (DE3).  
The permease and xplA were cloned individually and together into pET-YSBLIC3C 
(Section 4.2.1). The following constructs were obtained:  
• pET-YSBLIC3C containing XplA only (pET-A) 
• pET-YSBLIC3C containing the permease only (pET-P) 
• pET-YSBLIC3C containing XplA and the permease (pET-AP) 
The constructs were transformed into Rosetta 2 (DE3) and the following clones were 
obtained: XplA expressing (pET-A), permease expressing (pET-P) and XplA co-
expressed with permease (pET-AP). The insert size of these clones was checked by 
PCR analysis using primer specific to xplA and permease.  
4.3.4.1 Resting cell assays 
To investigate whether the presence of the permease enhanced RDX activity, resting 
cell assays were carried out. XplA expressing (pET-A), permease expressing (pET-P), 
XplA co-expressed with permease (pET-AP) and empty vector clones were incubated 
in minimal medium containing 80 µM RDX as a sole nitrogen source for 3 hours. 
Samples were taken at different time points for RDX and nitrite analysis.  
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Figure 4.4. Resting cells incubation (HPLC analysis). XplA expressing clone (triangles), 
XplA co-expressed with permease clone (diamonds), permease expressing clone (squares) and 
Rosetta 2 with empty vector (circles). Error bars show one standard deviation for triplicate 
samples. 
 
 
 
 
 
 
 
 
 
Figure 4.5. Resting cells incubation (Griess assay). XplA expressing clone (triangles), XplA 
co-expressed with permease clone (diamonds), permease expressing clone (squares) and 
Rosetta 2 with empty vector (circles). Error bars show one standard deviation for triplicate 
samples. 
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HPLC analysis (Fig. 4.4) revealed that after 1 hour of incubation, approximately 95 % 
(76 µM) of RDX was degraded by the XplA expressing (pET-A) clone and 120 µM of 
nitrite (degradation product) detected (Fig. 4.5). Complete RDX degradation by this 
clone was observed after 2 hours of incubation (Fig. 4.4). For XplA co-expressed with 
permease (pET-AP) clone, 42 % (34 µM) of the RDX was degraded, with 36 µM of 
nitrite production after 1 hour of incubation and approximately 66 % (53 µM) of RDX 
after 3 hours.  
For the permease expressing (pET-P) clone and the negative control, although a small 
(approx. 10 µM) decrease in RDX was seen in the first hour of incubation, no further 
decrease in the level of RDX was seen throughout the remaining incubation time. 
4.3.4.2 XplA activity in cell free extracts 
XplA activity in cell free extracts of XplA expressing (pET-A) and XplA co-expressed 
with permease (pET-AP) clones was measured described in Chapter 3 (3.2.1). Cell 
free extracts (0.01 g/ mL) were incubated in minimal medium with 100 µM of RDX. 
After 90 min of incubation, 95 % of the RDX had been removed from the medium when 
using the cell free extracts obtained from XplA expressing (pET-A) clone, whereas just 
50 % of the RDX was removed when using the extracts from XplA co-expressed with 
permease (pET-AP) clone (Fig. 4.6). Additionally, the SDS-PAGE analysis also 
revealed a more abundant band for XplA in cell free extract from the pET-A clone than 
pET-AP clone, where similar amounts of total protein were analysed (data not shown).  
 
 
 
 
 
 
 96 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. RDX removal using cell free extracts of XplA co-expressed with the permease 
(clone AP) compared to the XplA expressing control (clone A). Grey and white bars 
represent RDX concentration at 0 and 90 min of incubation, respectively. Error bars show one 
standard deviation for triplicate samples. 
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4.3.4.3 RDX uptake assays  
To compare the RDX uptake in cells of the permease expressing (pET-P) clone and 
Rosetta 2 (empty vector), induced cells (0.25 g/ mL) were incubated in potassium 
phosphate buffer (pH 7.4) with 80 µM of RDX. Samples were centrifuged at 14,000 x g 
for 5 min and supernatants directly used for HPLC analysis.  
 
 
 
 
 
 
 
 
Figure 4.7. RDX uptake in cells of the permease expressing clone (clone P) and Rosetta 2 
(empty vector). Grey and white bars represent RDX concentration at 0 and 30 min of 
incubation, respectively. Error bars show one standard deviation for triplicate samples. 
 
Cells of E. coli expressing the permease showed the same RDX uptake compared to 
the negative control (Rosetta 2 with empty vector) after 30 min of incubation (Fig. 4.7). 
Recombinant cells of E. coli did not remove more RDX than the control and SDS-
PAGE analysis did not reveal any significant expression of the permease (data not 
shown). Since no antibody against this permease was available, the expression of 
permease in permease expressing (pET-P) clone could not be monitored. Thus, no 
further analysis with this construct was performed.  
In order to monitor expression of the permease and study the uptake of RDX, the 
permease from strain 11Y was cloned into the N-terminal His-Tag expressing vector, 
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pET-YSBLIC3C and the permease sequence verified. The permease expressing clone 
was designated as Rosetta 2 pLICP2. 
4.3.4.4 Growth of induced and uninduced Rosetta 2 pLICP2 
It was reported that the expression of membrane proteins slows down the growth of 
host cells after induction (Miroux and Walker, 1996). To study the effect of induction on 
the growth of Rosetta 2 pLICP2, growth of induced and uninduced cells was compared. 
Rosetta 2 pLICP2 was grown in LB until OD600 approximately 0.5 and induction was 
performed. Another batch of cells was left to continue to grow without addition of IPTG. 
 
   
 
 
 
 
 
Figure 4.8. Effect of IPTG induction on growth of Rosetta 2 pLICP2. Uninduced cells 
(triangles) and induced cells (squares). Error bars show one standard deviation for triplicate 
samples. 
 
In Figure 4.8, it was clearly seen that the induced cells grew far slower than the 
uninduced cells.  
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4.3.4.5 Permease detection in the total protein fraction  
To detect the permease in the total protein fraction of Rosetta 2 containing pLICP2, 
western blot analysis was conducted. In the first expression trial, cells were harvested 
after 3 hours of IPTG induction. This time point was based on previously studies that 
found membrane proteins accumulated at high levels when cells were harvested at this 
time point (Miroux and Walker, 1996, Mulligan et al., 2009). However, no 
immunoreactive protein was detected in the total protein fraction of Rosetta 2 pLICP2 
(Fig. 4.9a-b) using anti-His antibodies. In the second expression trial, the incubation 
time was prolonged to 18 hours after the induction. The same result was observed; no 
band representing the permease was shown on the western blot (Fig. 4.9c).   
 
 
 
 
 
 
 
Figure 4.9. SDS-PAGE and western blots of total proteins of Rosetta 2 pLICP2. Rosetta 2 
pLICP2 was incubated at 37 °C and grown until OD600 0.5. The cultures were then induced by 
IPTG (1 mM) followed by incubation at 25 °C for 3 h (Trial 1) or 18 h (Trial 2). After cells were 
harvested, protein solubilisation buffer was added to the pellets to obtain the total soluble 
protein fraction. Samples were heated at 100 °C for 15 min prior to running onto the SDS-PAGE 
gels. (a) Western blot analysis (Trial 1), (b) 12 % SDS-PAGE (Trial 1), (c) Western blot analysis 
(Trial 2), (d) 12 % SDS-PAGE (Trial 2), (M) Protein marker, (P) Total protein of Rosetta 2 
pLICP2, (-ve) Rosetta 2 with empty vector, (+ve) positive control (partial purified His-Tagged 
Not 10 obtained from Marie Delenne).   
 
Thus to improve the limits of detection, it was decided to concentrate the permease by 
isolating the membrane protein fraction.  
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4.3.4.6 Permease detection in the membrane protein fraction 
The membrane proteins were firstly isolated from the Rosetta 2 pLICP2, which were 
grown at 25 °C degree for 3 hours after induction. Once the membrane proteins of 
Rosetta 2 pLICP2 were obtained, this fraction was run on SDS-PAGE gel followed by 
western blotting. No heating was applied to the samples before loading on the SDS-
PAGE gels as membrane proteins in the SDS loading buffer tend to form aggregates 
during the 100 °C heating process (personal communication, Christopher Mulligan).  
 
 
 
 
 
Figure 4.10. Detection of His-tagged permease. (a) Western blot analysis, (b) 12 % SDS-
PAGE, (M) Protein marker, (P1 and P2) Membrane proteins fraction of two batches of Rosetta 2 
pLICP2, (-ve) Rosetta 2 with empty vector, (+ve) positive control (partial purified His-Tag Not 
10).  
 
  
A band of approximately 40 kDa of immunoreactive species was present in the 
membrane fraction of both of the tested batches of Rosetta 2 pLICP2 (Fig. 4.10a), 
representing the molecular weight of the permease. The expressed permease was also 
seen on an SDS-PAGE gel (arrows). This immunoreactive species was not detected in 
membrane fraction of Rosetta 2 with empty vector (negative control). This indicates 
that the permease was successfully expressed in the membrane protein fraction. The 
molecular weight is slightly smaller than the predicted molecular weight (49 kDa); 
however, it is a common phenomenon that membrane proteins migrate faster in SDS-
PAGE gels (Mulligan, 2008). 
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4.3.4.7 Effect of temperature on the expression of the permease  
To assess the effect of temperature on the expression of the permease, Rosetta 2 
pLICP2 was incubated at 25 °C and 37 °C for 3 hours after the addition of IPTG.  
 
 
 
 
 
 
Figure 4.11. Permease expression at different induction temperature. (a) Western blot 
analysis, (b) 12 % SDS-PAGE. Cultures were grown in LB until OD600~0.5 and induced with 
IPTG. Cultures were incubated at 25 °C and 37 °C over a period of 3 h after the induction.  
 
The western blot analysis revealed that both batches of cells that were induced at 
different temperature (25 °C or 37 °C) produced a positive signal after incubating with 
His-tag antibody conjugated with peroxidase. This suggested the permease was 
expressed at both temperatures. However, expression was slightly higher at 25 °C (Fig. 
4.11a). Thus, the expression of the permease was performed at this temperature.  
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4.3.4.8 Effect of IPTG concentration on permease expression  
To investigate the effect of varying IPTG concentrations on the expression of the 
permease, Rosetta 2 pLICP2 was grown at 25 °C for 3 hours and induced at OD600 0.5 
with different IPTG concentration of 0, 0.1, 0.25, 0.5, 0.75 and 1 mM. 
 
 
 
Figure 4.12. Effect of IPTG concentration in permease expression. Western blot with anti 
His-tag antibody of the induced Rosetta 2 pLICP2 in various concentration of IPTG (0-1 mM). 
Cells were harvested after 3 h of IPTG induction.  
 
 
A positive signal with a molecular mass of approximately 40 kDa was detected in all 
Rosetta 2 cells induced with IPTG by western blot analysis. When cells were induced 
with 0.25 mM of IPTG the strongest signal was obtained (Fig. 4.12). Similar amounts of 
permease were detected when cells were induced with 0.5, 0.75 or 1 mM of IPTG. The 
optimal concentration of 0.25 mM was used to induce Rosetta 2 pLICP2 in consecutive 
experiments.  
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4.3.4.9 Purification of permease and peptide mass 
fingerprinting 
To identify if the protein species with a molecular mass of ~40 kDa on the SDS-PAGE 
gel was the rhodococcal permease, it was purified and peptide mass fingerprint was 
performed.  
 
 
 
 
 
 
 
Figure 4.13. Purification of permease using Nickel column. Rosetta 2 pLICP2 were grown 
under the optimum conditions. The membrane proteins were harvested and were solubilised 
using 0.5 % of n-dodecyl-β,D-maltoside (Lemuh et al., 2009). The soluble membrane proteins 
were incubated with resin (nickel column) for 1.5 hours. Elution was carried out after a single 
washing step. The eluates were analysed using SDS-PAGE gel. (M) Protein marker, (SR) 
solubilisation reaction, (IMP) insoluble membrane proteins, (SMP) soluble membrane proteins, 
(FT) flow through, (W) washing step, (E1-E3) elutions of permease.   
 
The permease was successfully purified using the nickel resins. Figure 4.13 shows a 
strong band in the eluted sample (E2) with a molecular weight of ~40 kDa. This band 
was cut from the gel and sent for peptide mass fingerprint analysis (performed by 
Technology Facility at the University of York), which confirmed that this band contained 
protein matched to the strain 11Y permease, thus confirming the immunoreactive 
species observed in the western blot analysis was the permease.  
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4.3.4.10 Whole cell RDX uptake assays   
To functionally characterise the rhodococcal permease, RDX uptake assays were 
carried out using whole cells of Rosetta 2 pLICP2 (method adapted from Mulligan, 
2008).  
 
 
 
 
 
 
 
 
Figure 4.14. Uptake of RDX by induced and uninduced Rosetta 2 pLICP2. The induced and 
uninduced cells (final concentration: 0.05 g/mL) were suspended in potassium phosphate 
buffer. RDX was added and samples were taken at 0, 4, 7 and 10 minutes with continuous 
stirring. Samples were centrifuged and supernatants were taken for RDX measurement by 
HPLC. Induced cells (squares), Uninduced cells (triangles). 
 
Six uptake assays from three batches of cells were carried out individually. Whilst on 
average the induced cells gave a slightly higher rate of RDX uptake, this difference was 
not significant (Fig. 4.14). Additionally, uptake assays at higher RDX concentration (90 
µM) also showed no difference in the RDX uptake rates between the induced and 
uninduced cells (data not shown). This indicates that the presence of permease in 
Rosetta 2 pLICP2 did not significantly enhance the RDX uptake.  
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4.4 Discussion 
The transcription of the putative permease and xplA in strain 11Y were upregulated 
significantly when RDX was used as the sole nitrogen source compared to when cells 
were grown in the absence of RDX. Interestingly, when ammonium chloride was 
supplied together with RDX, both genes were downregulated compared to when RDX 
was the only nitrogen supply. The similar trend of expression in both permease and 
xplA suggests that both of these genes are under the same regulation and the putative 
transporter could be involved in RDX transport.  
The architecture of cell walls in Gram-positive and Gram-negative bacteria is different. 
Gram-positive bacteria possess a cell membrane which is bordered by a thick 
peptidoglycan layer. Cell walls of Gram-negative bacteria comprise of an inner cell 
membrane, followed by a thin peptidoglycan layer and an additional outer membrane. 
Due to these differences, expressing a Gram-positive transporter in E. coli could be 
challenging. However, reports in the literature describe that transporters from Gram-
positive bacteria including a rhodococcal transporter were successfully expressed and 
functionally characterised in E. coli (Degen et al., 1999, Komeda et al., 1997, Zolotarev 
et al., 2008). Therefore, the 11Y permease was expressed in E. coli for 
characterisation.   
Assuming that the 11Y permease is a RDX transporter, it was expected that XplA co-
expressed with the permease, would increase RDX degradation compared to when 
XplA was expressed alone. To investigate this, both permease and xplA were cloned 
individually and together into a vector to produce three clones: E. coli expressing XplA, 
E. coli expressing the permease and E. coli co-expressing both XplA and the 
permease. Cell free extract assays showed that the clones expressing XplA produce 
higher levels of XplA compared to clones expressing both proteins. This is perhaps not 
surprising as the total amount of recombinant protein expressed is often reduced by the 
number of expressed genes (Johnston et al., 2000, French et al., 1995). The different 
levels of XplA activity in XplA expressing and XplA co-expressed with permease cells 
when expressed under the same condition, coupled with the lack of a permease 
antibody meant that these studies were inconclusive in determining involvement of the 
permease in RDX degradation. 
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The co-expression strategy in this study used two genes on a single vector under the 
control of a single promoter. There are alternative co-expression compatible vectors 
that could have been used such as pETDuet-1 (Novagen) and pRSFDuet-1 (Novagen). 
However, these alternative vectors have the same limitation in that the amount of 
protein produced will generally be reduced when two genes are expressed in the E. coli 
host compared to when one gene is expressed.  
Following use of pET-YSBLIC3C as the expression system for the permease and xplA, 
both resting cell and cell free extract assays confirmed that the XplA was successfully 
expressed when co-expressed with the permease. Since the permease was cloned 
upstream of the actively expressed XplA, it is likely that the permease was transcribed. 
However, without a permease-specific antibody, it was not possible to determine 
whether this rhodococcal permease was successfully integrated as a membrane 
protein in E. coli. Therefore, a His-tagged permease construct was produced to monitor 
the expression of this membrane protein.     
As described in section 4.3.4.4, the growth of the permease expressing clone was 
slowed down after IPTG induction (Fig. 4.8). This phenomenon is commonly observed 
in bacteria recombinantly expressing membrane proteins under the control of the T7 
promoter (Miroux and Walker, 1996, Mulligan, 2008). The bacteriophage T7 RNA 
polymerase is approximately seven times more efficient than the E. coli RNA 
polymerase. This high activity of T7 RNA polymerase can result in uncoupling of 
transcription and translation (Miroux and Walker, 1996), whereby more mRNAs are 
produced, but fewer proteins are translated. The effect of uncoupling of transcription 
and translation causes cells grows slowly after the IPTG induction.   
The E. coli strains C41 (DE3) and C43 (DE3), which are derived from the commercial 
strain BL21 (DE3) have better growth rate than BL21 (DE3) after IPTG induction during 
membrane protein expression (Miroux and Walker, 1996). The expression of 
membrane proteins in C41 (DE3) and C43 (DE3) was found to be higher than in the 
parent strain BL21 (DE3). Therefore, these strains have been widely used to express 
membrane proteins by various research groups (Masi et al., 2003, Mohanty and 
Wiener, 2004, Mokhonov et al., 2005, Quick and Wright, 2002, Lucet et al., 1999, 
Mulligan, 2008).  
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Since BL 21(DE3) does not have additional copies of specific tRNA genes that are rare 
in E.coli, both C41 (DE3) and C43 (DE3) derived from BL 21 (DE3) are unlikely to 
supply tRNAs for rare codons. There are rare codons present in xplA and permease, it 
was thus decided not to use C41 (DE3) and C43 (DE3) as hosts for expression in the 
expression studies. Instead, Rosetta 2 (DE3) was employed to express permease and 
xplA as this strain supply tRNAs rare codons. Successful permease and XplA 
expression were achieved as reported in result sections of this chapter.  
Initial trials of His-tagged permease expression failed to detect the putative transporter 
in the total proteins by western blot, as shown in Figure 4.9. By isolating the membrane 
protein fraction, a band with the molecular mass of approximately 40 kDa was 
detected. Variation of the IPTG concentration resulted in altered permease expression 
levels in this study (section 4.3.4.8). The maximum yield was achieved when 0.25 mM 
IPTG was used for induction.  
Expression could be further increased by inducing the Rosetta 2 pLICP2 at 25 °C 
compared to 37 °C as shown by the western blot analysis (section 4.3.4.7). Different 
optimal temperatures for the expression of membrane proteins have been reported 
(Lucet et al., 1999, Quick and Wright, 2002, Drew et al., 2006, Mokhonov et al., 2005, 
Mulligan, 2008, Eriksson et al., 2009). In general, the optimum temperature for 
membrane protein expression ranges between 20 °C and 25 °C, it has been suggested 
that this temperature range is the preferred temperature for optimum membrane 
proteins expression (Eriksson et al., 2009). Examples of membrane proteins that were 
successfully expressed at this range of temperature were a membrane 
glycosyltransferase (Eriksson et al., 2009), the integral membrane protein SpoIIE 
(Lucet et al., 1999), a TRAP transporter YiaN (Mulligan, 2008) and a putative amino 
acid transporter YbaT (Drew et al., 2006). However, another study reports that a 
formate-nitrite transporter TpNirC was expressed optimally at 37 °C (Beckham et al., 
2010).  
Whole cell RDX uptake assays (section 4.3.4.10) demonstrated that the permease 
expressing clone (Rosetta 2 pLICP2) did not show higher RDX uptake over the 
incubation time compared to the control. It would be interesting to purify the permease 
in high yield and reconstitute this transporter into liposomes. In vitro RDX uptake 
assays could be performed using the constructed proteoliposomes. However, as radio 
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labelled RDX, required for this method, was not available in the UK, the proteoliposome 
approach was not attempted.  
Alternately, it was decided to delete the permease in strain 11Y by using an unmarked 
gene deletion system (van der Geize et al., 2001). The next chapter reports the 
construction and characterisation of a permease knockout strain derived from strain 
11Y.  
 
 
 
 
 
 
 
 
 
 
 109 
Chapter 5 
Construction and characterisation of 
rhodococcal knockout strains 
5.1 Introduction 
Two distinct, plasmid encoded, gene clusters flanking xplA were isolated as described 
in Section 1.10 (Andeer et al., 2009, Indest et al., 2010). One characterised gene 
cluster, from Gordonia sp. strain KTR9, contains four open reading frames (Figure 
1.11)  (Indest et al., 2010). The second gene cluster is from Rhodococcus rhodochrous 
strain 11Y (Fig. 5.1), which is highly conserved amongst the RDX degrading bacteria 
including the Microbacterium sp. MA1 (North America), Rhodococcus DN22 (Australia), 
Rhodococcus spp. (Belgium and UK), and has not been characterised yet. Because 
this gene cluster is highly conserved amongst strains from geographically distinct 
regions, it was considered that further characterisation of these genes with respect to 
RDX metabolism was warranted.  
 
 
 
Figure 5.1. Organisation of the RDX degradation gene cluster in R. rhodochrous 11Y.  
 
To characterise the xplA gene cluster in strain 11Y, an unmarked gene deletion system 
was employed to generate four knockout strains: MarR, permease, xplB and xplA 
knockouts (van der Geize et al., 2001). This method involves the use of a mutagenic 
plasmid (pK18mobsacB) and a donor strain E. coli S17-1. The pK18mobsacB was 
previously derived from a small plasmid pK18 isolated from E. coli, with modifications 
to have a broad-host-range transfer machinery of plasmid RP4 (oriT), multiple cloning 
xplA xplB permease      MarR 
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site, kanamycin resistance and sucrose sensitive sacB genes (Schäfer et al., 1994). 
The presence of RP4 allows the plasmid to be transferred into a wide range of Gram-
positive and Gram-negative bacteria via conjugation. This feature is crucial as DNA 
manipulation in Gram-positive bacteria is often hindered by the lack of highly efficient 
transfer systems. This mutagenic plasmid has previously been successfully used to 
construct a marker-free gene deletion in variety of strains (van der Geize et al., 2001, 
Yang et al., 2007, Rosloniec et al., 2009, Okamoto et al., 2010). In short, the mutagenic 
plasmid is firstly transferred from the donor strain (E. coli S17-1) into the recipient strain 
(strain 11Y wild-type). The first homologous recombination occurs resulting in 
incorporation of the mutagenic plasmid into the genome of strain 11Y, producing a 
kanamycin resistant and sucrose sensitive strain (1st mutant). At this stage, the gene to 
be deleted (the target gene) is still present in the genome. Following a second cross-
over event, the mutagenic plasmid, together with the target gene, is removed creating a 
gene deleted mutant (2nd mutant) (Figure 5.2).     
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Figure 5.2. The principle of the construction of a gene-deleted strain using the unmarked 
gene deletion system (van der Geize et al., 2001).   
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5.2 Materials and methods 
5.2.1 Inserts preparation 
To construct the mutagenic plasmids, inserts were generated (Fig. 5.3) using the 
primers listed in Table 2.1 (Chapter 2). The upstream sequence (Insert 1) of the 
regulator, permease, xplB and xplA were all individually amplified to produce PCR 
products with EcoRI and NdeI restriction sites at the 5’ and 3’ end. The downstream 
regions (Insert 2) of four of the individual genes were amplified to produce PCR 
products with the NdeI and HindIII restriction sites at the 5’ and 3’ end. The PCR 
products were purified and the DNA concentration determined. 
 
 
 
Figure 5.3. Generation of inserts (upstream and downstream sequences of target gene) 
using primers listed in Table 2.1 (Chapter 2).  
 
 
5.2.2 Plasmids construction  
Digestions were carried out as described in Chapter 4 (Section 4.2.1) with some 
modifications. The EcoRI and NdeI restriction enzymes were used to digest Insert 1 
and HindIII and NdeI were used to digest Insert 2 (Figure 5.3). The plasmid (Fig. 5.4) 
was digested with EcoRI and HindIII and digested products separated on an agarose 
gel, purified and then plasmid dephosphorylated before ligation. Ligation and 
transformation was carried out as described in previous chapters (Section 2.6.6 and 
4.2.1). 
 
 
Target gene 
  Insert 1    Insert 2 
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Figure 5.4. Plasmid map of pK18mobsacB.  
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5.2.3 Screening, selection and validation of positive clones 
To check whether the clones carried the correct inserts, colony PCR were performed 
using primers as shown in Table 5.1. Clones that carried the correct size of PCR 
product were selected. To validate the positive constructs, they were checked after 
digesting with restriction enzymes. Once the plasmids (constructs with correct inserts) 
were made, they were maintained in E. coli (Novablue).  
 
Table 5.1. Primers used to check inserts size. Colony PCR using an annealing 
temperature of 58 °C, yielded PCR products with predicted size. For further details of 
primers see Chapter 2 (Table 2.1). 
 
Mutagenic plasmid for gene 
deletion Primers 
Size of 
product  
regulator (ORF 27) UpF861(rp)+EcoRI and 
DwnR852(rp) +HindIII 1.7 kb 
permease (ORF 29) UpF822(perm)+EcoRI 
and 
DwnR975(perm)+HindIII     
1.8 kb 
xplB (ORF 31) UpF1083(xplB)+EcoRI 
and 
DwnR849(xplB)+HindIII 
1.9 kb 
xplA (ORF 32) UpF816(xplA)+EcoRI and 
DwnR975(xplA)+HindIII 1.8 kb 
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5.2.4 Transconjugation 
The recipient strain, R. rhodochorous 11Y was spread onto LBP agar supplemented 
with nalidixic acid (30 µg/mL) and incubated at 30 °C for 5 days. Each mutagenic 
plasmid (pK18mabsacB-xplA, pK18mabsacB-xplB, pK18mabsacB-permease, and 
pK18mabsacB-MarR) was transformed into E. coli S17-1 (donor strain). After 24 hours 
of incubation, about 1000 transformants were obtained on a LBP agar supplemented 
with kanamycin (25 µg/mL). The plate was incubated for another 24 hours at room 
temperature then 2 mL of LBP medium was added onto both the recipient and donor 
strain agar. Cells was harvested and transferred into an Ependoff tube. Aliquots of 750 
µL of both strains were gently mixed together and followed by centrifugation at 8,000 x 
g for one minute. Cells were resuspended in 1 mL of LBP and 200 µL aliquots were 
spread onto non-selective agar. All plates were incubated at 30 °C overnight. After the 
incubation, 2 mL LBP was added to the plates and cells were harvested. Cells were 
diluted into 2 and 4-fold and aliquots (100 µL) were spread on LBP agar supplemented 
with nalidixic acid (30 µg/mL) and kanamycin (50 µg/mL). Transconjugants appeared 
after 3-4 days incubation and colonies that were kanamycin resistant and sucrose 
sensitive were selected. Colony PCR using primers specific to sacB was performed to 
further confirm the presence of the mutagenic plasmid in the recipient strain.  
5.2.5 Second cross-over  
Sucrose sensitive derivatives of strain 11Y (1st mutant) were grown in 10 mL of non-
selective LBP medium at 30 °C, 120 rpm overnight. Cells were diluted into 2, 4 and 10-
folds and aliquots (100 µL) spread on LBP agar supplemented with nalidixic acid (30 
µg/mL) and sucrose (10 % w/v). Sucrose resistant colonies grew after 2-3 days 
incubation at 30 °C and colonies that were sucrose resistant and kanamycin sensitive 
were selected for screening for the gene deletion in the strain.  
5.2.6 Screening and selection of gene deleted strain 
Gene deletion was confirmed by PCR using gene specific primers (Table 5.1) 
amplifying from the external region of the deleted genes. The gene deleted mutants 
produced shorter PCR products than the wild-type.  
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5.3 Results 
5.3.1 Construction of knockout strains 
5.3.1.1 Empty plasmid validation  
After receipt of the plasmid pK18mobsacB, the sample was reconstituted into 
nuclease-free water and transformed into E. coli (Novablue). Two colonies that grew on 
kanamycin selective agar were selected. These colonies were streaked onto agar 
plates containing sucrose (10 % w/v). None of the colonies were able to grow on agar 
plates containing sucrose indicating that the sacB was expressed and active.  
To check the size of the plasmid, purified plasmid was digested with EcoRI or HindIII, 
as restriction sites of these enzymes were located on multiple cloning sites of the 
plasmid. Plasmid digestion showed the size of linearied plasmid was about 5.6 kb (Fig. 
5.5), which is within range of the size of pK18mobsacB (Fig. 5.3).  
 
 
 
 
 
 
Figure 5.5. Undigested and digested plasmid of pK18mobsacB from two selected 
colonies. Lane 1 and 8: Undigested plasmid with no dilution. Lane 2 and 7: Undigested plasmid 
with 20x dilution. Lane 3 and 5: EcoRI-digested plasmid. Lane 4 and 6: HindIII-digested 
plasmid. 
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5.3.1.2 Construct validation 
To validate the gene knockout plasmids for the regulator, permease, xplB and xplA, the 
DNA was digested with restriction enzymes (EcoRI, NdeI and/or HindIII). A typical 
result of the plasmid digestions is shown in Figure 5.6. All of the digestions produced 
the expected sized products. Thus, these mutagenic plasmids were used for the 
following experiments. 
 
 
 
 
 
 
 
 
 
Figure 5.6. Plasmid digestions. A-D were the typical digestions of mutagenic plasmid that 
used for gene deletion of permease, regulator, xplA and xplB, respectively. Lane Un: 
undigested plasmid. Lane Ai and Bi: plasmid digested with EcoRI, NdeI and HindIII. Lane Aii, Bii 
and Ciii: plasmid digested with EcoRI and NdeI. Lane Aiii, Biii, Cii and Dii: plasmid digested with 
NdeI and HindIII. Lane Ci: plasmid digested with EcoRI and HindIII. Lane Di: plasmid digested 
with EcoRI. All of the digestions showed correct size of the predicted products. 
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5.3.1.3 Transconjugation 
After the transconjugation process for all sets of gene deletion experiments, 100 
kanamycin resistant colonies (Fig. 5.7)  derived from R. rhodochorous 11Y were grown 
on sucrose (10 % w/v) containing agar and sucrose sensitive colonies were selected 
(Fig. 5.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7. The 100 selected colonies growing on kanamycin containing agar. Colonies 
were incubated at 37 °C for 2 days. 
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Figure 5.8. Sucrose sensitive colonies after transconjugation process. A 100 of the 
selected colonies were grown on to kanamycin (50 µg/mL) and sucrose (10 % w/v) containing 
LBP agar. As positive control, all colonies were grown on LBP agar without sucrose. They were 
incubated at 37 °C for 2 days.  
-sucrose +sucrose 
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Figure 5.9 shows that the sacB gene was amplified from all of the colonies that carried 
the mutagenic plasmid confirming that the mutagenic plasmid has been transferred into 
R. rhodochorous 11Y.  
 
 
 
 
 
 
 
Figure 5.9. Detection of sacB. All of the PCR reaction produced the expected size (770 bp) 
using primers specific to sacB. Positive control: pK18mobsacB. Negative control: strain 11Y 
wild-type. 
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5.3.1.4 Gene-deleted strains 
To generate the gene-deleted strains, one of the sucrose sensitive colonies was grown 
on non-selective medium (LBP medium without kanamycin and sucrose) for 24 h. Cells 
were spread onto sucrose containing agar and the sucrose resistant mutant left to grow 
(Fig. 5.10). 
 
 
 
 
 
 
 
 
 
Figure 5.10. Sucrose resistant colonies on sucrose containing agar 
 
Of the 100 sucrose resistant colonies that were randomly selected and grown on 
kanamycin containing agar, more than 80 % of the colonies were unable to grow (data 
not shown). This indicates that the mutagenic plasmid was likely removed from these 
colonies. To further confirm the removal of plasmid from the colonies, a total of 26 of 
these colonies were selected for PCR amplification using primers specific to sacB. The 
result (Fig. 5.11) reveals that PCR products were not amplified indicating that the 
mutagenic plasmid has been removed from sucrose resistant colonies.  
 
 
 
 
No dilution 2x dilution 
4x dilution 10x dilution 
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Figure 5.11. Detection of sacB. No PCR product was generated using primers specific to sacB 
in the selected colonies. Positive control: pK18mobsacB. Negative control: strain 11Y wild-type. 
 
To identify the gene-deleted strains, the external primers (see caption of Figure 5.12) 
were used to amplify the external region (upstream and downstream) of the deleted 
gene.  As a result, a shorter PCR product (about 1.8 kb) was amplified from the gene-
deleted colonies compared to that amplified from the wild-type of R. rhodochrous 11Y 
(Fig. 5.12A-D). The xplA, xplB, permease or MarR gene sequence was deleted in all 
four selected gene-deleted strains, confirmed by sequencing. 
 
 
 
 
 
 
 
 
Figure 5.12. Identification of the gene-deleted strains. Primers used in PCR amplification in 
reaction (A): UpF822(perm) and DwnR975(perm); (B): UpF861(rp) and DwnR852(rp); (C): 
UpF816(xplA) and DwnR975(xplA); (D): UpF1083(xplB) and DwnR849(xplB). The expected 
product for the gene-deleted strain is about 1.8 kb. A shorter PCR product was amplified in the 
gene deleted strains.          
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5.3.2 Characterisation of the knockout strains 
5.3.2.1 Characterisation of the xplA knockout strain 
It is known that there is more than one polychlorinated biphenyl (PCB) degrading 
system in Rhodococcus sp. (Seto et al., 1995). To investigate whether there are any 
additional RDX degrading gene(s) present in strain 11Y, the xplA knockout strain was 
constructed.  
The xplA knockout and wild-type strains were incubated in minimal medium, with RDX 
as a sole nitrogen source at a concentration of 150 µM, over 48 h of incubation. Growth 
of the strains and RDX elimination throughout the incubation time were monitored. 
HPLC analysis revealed that whilst the wild-type strain 11Y removed all of the RDX in 
the minimal medium within 8 h, no RDX removal was observed with the knockout strain 
over 48 h of incubation (Fig. 5.13). The growth of the xplA knockout strain reached and 
OD600 of 0.6 after 48 h of incubation which is probably due to the carry-over of nitrogen 
source from inoculum (LB-grown cells) or the knockout strain utilised nitrogen from 
dead cells for growth.   
 
 
 
 
 
 
 
 
 
Figure 5.13.  Growth of the xplA knockout strain and wild-type on RDX minimal medium. 
RDX concentration for wild-type (closed triangles) and xplA knockout strain (open triangles). 
OD600 for wild-type (closed squares) and xplA knockout strain (open squares). Error bars show 
one standard deviation for triplicate samples. 
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5.3.2.2 Western blot analysis 
To check that XplA was absent in the knockout strain, western blot analysis was 
carried out; no XplA was detected in the knockout cell free extract (Fig. 5.14) while the 
positive control (11Y wild-type) showed a band of correct molecular weight (60 kDa).  
 
 
 
 
 
 
 
 
Figure 5.14. Western blot analysis of cell free extracts of xplA knockout and wild-type 
strains. (M): Protein marker. (1): WT cell free extracts (0.1 g/mL). (2): xplA knockout cell free 
extracts (0.1 g/mL).  
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5.3.2.3 Resting cell assays of the xplA knockout strain 
Resting cell incubations of the xplA knockout and wild-type strains of 11Y were 
performed in minimal medium containing 90 µM of RDX, at room temperature 
(approximately 20 °C) over 60 minutes. Wild-type cells removed all of the RDX in the 
medium within 30 minutes. No RDX removal by the knockout strain was observed over 
the incubation time (Fig. 5.15).    
 
 
 
 
 
 
 
 
 
Figure 5.15.  Resting cell assays for wild-type and the xplA knockout strains of R. 
rhodochrous 11Y. The data show RDX concentration at incubation time of 0 min (grey bars), 
10 min (white bars), 30 min (vertical bars) and 60 min (horizontal bars). Error bars indicate one 
standard deviation for triplicate samples.  
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5.3.2.4. Growth of the xplA knockout strain on RDX dispersion 
agar 
RDX dispersion agar is a minimal medium, agarose-grade agar containing 5 mM RDX 
as the sole source of nitrogen. The agar has a white, opaque appearance due to 
insoluble RDX crystals. All of the RDX degrading bacteria isolated so far produce a 
zone of clearance, where the opacity disappears, around the edge of the colony. The 
mechanism behind the zone of clearance still remains unknown and to investigate this, 
the xplA knockout strain was grown on RDX dispersion agar supplemented with an 
additional nitrogen source (NH4Cl, KNO3 or NaNO2). The results demonstrated that 
there was no zone of clearance formed by the xplA knockout strain in the RDX 
dispersion agar supplemented with another nitrogen source (NH4Cl, KNO3 or NaNO2) 
(Fig. 5.16). This shows that the formation of a zone of clearance by the wild-type strain 
has a direct relationship to XplA activity.  
 
 
 
 
 
 
 
Figure 5.16. The xplA knockout and wild-type strains on RDX dispersion agar. These agar 
were supplemented with 5 mM of RDX and 250 µM of (A) NH4Cl; (B) KNO3 and (C) NaNO2. 
Strains were allowed to grow at 30 °C for 2 weeks.  
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5.3.2.5 Characterisation of the xplB knockout strain 
To determine whether XplB is the sole reductase partner for XplA, an xplB knockout 
strain was constructed. Sequencing analysis confirmed that xplB had been removed 
and that the coding sequence of the neighbouring xplA gene was unaltered. To 
compare the RDX-degrading ability of the xplB knockout strain with that of the wild-
type, both strains were grown in minimal medium containing 150 µM RDX as the sole 
nitrogen source. The growth (OD600) and RDX removal were monitored over the 48 h of 
incubation time (Fig. 5.17). The xplB knockout strain removed RDX at a rate of 3.1 
µM/h and removed all the RDX within 48 h with the OD600 reaching 1.0 after 48 h. The 
wild-type removed RDX at the faster rate of 18.8 µM/h.  
 
Figure 5.17. Growth of the xplB knockout strain and wild-type strains on RDX as a sole 
nitrogen source. RDX concentration for wild-type (closed triangles) and xplB knockout strain 
(open triangles). OD600 for wild-type (closed squares) and xplB knockout strain (open squares). 
Error bars show one standard deviation for triplicate samples. 
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5.3.2.6 Resting cell assays for the xplB knockout strain 
A comparison of RDX removal by resting cells of the xplB knockout and wild-type 
strains was carried out. The pattern of RDX removal was consistent with the growth 
experiments described above (5.3.2.5). When resting cells were incubated in RDX 
minimal medium, approximately 83 % of the RDX was removed by the wild-type strain 
and 12 % by the knockout strain during the 10 min incubation time (Fig. 5.18).  
 
 
 
 
 
 
 
 
 
Figure 5.18.  Resting cell assays for wild-type of R. rhodochrous 11Y and the xplB 
knockout strains. The data show RDX concentration at incubation time of 0 min (grey bars), 10 
min (white bars), 30 min (vertical bars) and 60 min (horizontal bars). Error bars indicate one 
standard deviation for triplicate samples.  
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5.3.2.7 Quantitative RT-PCR and western blot analysis for the 
xplB knockout strain 
The reduced rate of RDX removal in the xplB knockout strain compared to wild-type 
could be due to a lower level of xplA transcript or protein. To investigate this, real time 
PCR and western blots were performed. Cell free extracts of wild-type and the 
knockout cells grown in RDX minimal medium were prepared and RNA and protein 
extracted.  
 
 
 
 
 
 
 
Figure 5.19. SDS-PAGE and western blot of cell free extracts of strain 11Y wild-type and 
the xplB knockout strains. (A) 12 % SDS-PAGE (B) Western blot analysis for XplA.  
 
Transcriptional analysis revealed that the xplB knockout and wild-type strain had 
similar levels of xplA expression (data not shown). Nevertheless, western blot analysis 
demonstrated that XplA expression was lower in the xplB knockout strain compared to 
the wild-type strain (Fig. 5.19).  
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5.3.2.8 Characterisation of the permease knockout strain 
Real time PCR analysis of the permease and xplA genes in wild-type 11Y 
demonstrated that both genes were up-regulated in the presence of RDX (Section 
4.3.2). This finding indicated that the permease could be involved in RDX uptake in 
strain 11Y. Thus, a permease knockout strain was constructed (Fig. 5.12). Growth 
experiments revealed that RDX degradation and growth rates for the knockout and 
wild-type strains were nearly identical (Fig. 5.20). Additionally, resting cell assays 
showed no difference in the RDX removal rates between the permease knockout and 
wild-type strains (data not shown).  
 
Figure 5.20.  Growth of the permease knockout strain and WT on RDX as a sole nitrogen 
source. RDX concentration for WT (closed triangles) and permease knockout strain (open 
triangles). OD600 for WT (closed squares) and permease knockout strain (open squares). Error 
bars show one standard deviation for triplicate samples. 
 
To investigate whether the putative permease has higher affinity toward RDX at a lower 
RDX concentration, the knockout and wild-type strains were incubated in minimal 
medium containing 40 µM RDX over 8 hours of incubation time.  
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Figure 5.21. RDX removal by the permease knockout and wild-type strains at a lower RDX 
concentration. RDX concentration for WT (closed squares) and permease knockout strain 
(open squares). Error bars show one standard deviation for duplicate samples. 
 
No significant differences in RDX degradation were observed in either of the strains 
(Fig. 5.21).  
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5.3.3 Initial investigation of xplA regulation in strain 11Y 
5.3.3.1 Studies under nitrogen-limiting conditions and RDX 
Earlier studies suggested that RDX degrading activity in strain 11Y is induced by RDX 
(Seth-Smith, 2002). To investigate whether expression of XplA in strain 11Y is induced 
when cells are exposed under nitrogen-limiting/starving conditions or to RDX as sole 
nitrogen source, cells were grown under a range of nitrogen conditions. Cells were 
grown overnight (17 h) in medium containing the nitrogen sources described below 
(Table 5.2), after which time, the cells were harvested and transferred into new medium 
for a further 3 hour incubation.   
Table 5.2. Growth and the treatment media. Cells (0.1 mg/mL) were inoculated into 
the growth medium (700 mL) and incubated at 30 °C with shaking (180 rpm) for 17 
hours. After the harvesting of cells, same amount of cells (2 mg/mL) were transferred 
into the treatment medium (250 mL) for 3 hours incubation.   
 
 
 
 
 
 
 
 
After 3 hours of treatments, cells were used for subsequent experiments: resting cell 
assays, western blot analysis, cell free extract activity assays and quantitative real time 
PCR.  
(a) 750 µM KNO2   450 µM KNO2   
(b) 5 mM KNO3   5 mM KNO3   
3 hours treatment   Growth medium   
(c) 750 µM KNO3   450 µM KNO3   
(d) 750 µM KNO3   No nitrogen (starving)   
(e) 750 µM KNO3   150 µM RDX   
(f) 250 µM RDX   150 µM RDX   
 133 
Resting cell incubations were performed in minimal medium with 100 µM of RDX at 30 
°C over 60 minutes (Figure 5.22). Cells treated with (b) 5 mM KNO3 (closed squares) 
had the lowest RDX removal rates. Cells treated in (a and c) nitrogen-limiting (open 
triangles and closed circles) and (d) starving (open diamonds) conditions were able to 
take up RDX more quickly than cells grown in (b) unlimiting nitrogen conditions (5 mM 
KNO3). Interestingly, the RDX uptake rates were further increased in (e and f); cells 
grown overnight and/or treated for 3 h in RDX (closed triangles and open squares). The 
cells with the longest pre-incubation exposure to RDX (f) (closed triangles) 
demonstrated the highest RDX uptake of all the treatments.     
 
Figure 5.22. RDX degradation by whole cells of R. rhodochrous 11Y under different 
nitrogen conditions. RDX-grown cells treated with 150 µM RDX (closed triangles), KNO3-
grown cells treated with 150 µM RDX (open squares), KNO3- grown cells treated with 450 µM 
KNO3 (open triangles), KNO2-grown cells treated with 450 µM KNO2 (closed circles), KNO3-
grown cells treated with no nitrogen medium
 
(open diamonds), KNO3-grown cells treated with 5 
mM KNO3 (closed squares), no cells control (closed diamonds) Error bars show one standard 
deviation for duplicate samples.  
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To monitor the XplA expression when cells of R. rhodochrous 11Y were exposed to 
different nitrogen conditions, western blot analysis was performed. The analysis 
revealed that the expression of XplA was higher in cells which were grown overnight 
and then treated for 3 h to RDX (condition (f) in Table 5.2) compared to cells treated 
with the other nitrogen sources (KNO2, KNO3) or no nitrogen (Figure 5.23). 
 
 
 
 
 
 
Figure 5.23. Western blot analysis of cell free extracts of strains 11Y from different 
nitrogen treatments. (a) KNO2-grown cells treated with KNO2 (450 µM); (b) KNO3-grown cells 
treated with KNO3 (5 mM); (c) KNO3-grown cells treated with KNO3 (450 µM); (d) KNO3-grown 
cells treated with no nitrogen; (e) KNO3-grown cells treated with RDX (150 µM); (f) RDX-grown 
cells treated with RDX (150 µM). Same amount of proteins (14 µg) were loaded onto the SDS-
PAGE gel.   
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Activity assays in cell free extracts were also performed. These were carried out by 
monitoring the depletion of NADPH at 340 nm. The results demonstrated that the 
specific activity of XplA could be measured in cells treated with RDX. RDX-grown cells 
treated with RDX (condition (f) in Table 5.2) showed higher specific XplA activity than 
nitrate-grown cells treated with RDX (condition (e) in Table 5.2). No activity was 
detected in cells exposed to KNO3, KNO2 or no nitrogen (Figure 5.24) (condition (a), 
(b), (c) and (d) in Table 5.2). This result was in agreement with data obtained from the 
resting cell assays and western blot analysis that higher XplA activity and amount of 
XplA was detected in the RDX-exposed cells (Figure 5.22 and 5.23).  
 
 
 
Figure 5.24. Specific XplA activity in cells treated with different nitrogen sources. RDX 
(condition (e) in Table 5.2); RDX/RDX (condition (f) in Table 5.2). Results are mean of three 
technical replicates of two biological measurements. N/D: Not detected.     
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The transcript levels of xplA in cells treated under different nitrogen conditions 
throughout the 3 hours incubations were monitored (Fig. 5.25). The xplA transcript 
levels of cells treated with high nitrogen source (5 mM KNO3) were generally low 
throughout the incubation time (closed squares). Cells treated with low nitrite/nitrate, no 
nitrogen or RDX had higher XplA transcript levels than high-nitrogen treated cells. No 
increase in transcription was seen either of the RDX treatments compared to low 
nitrogen-treated and nitrogen-starving cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.25. Transcript levels of xplA at different time points of the whole cell studies. 
KNO2-grown cells treated with 450 µM KNO2 (closed triangles), KNO3-grown cells treated with 5 
mM KNO3 (closed squares), KNO3-grown cells treated with 450 µM KNO3 (open triangles), 
KNO3-grown cells treated with no nitrogen medium (open diamonds), KNO3-grown cells treated 
with 150 µM RDX (open squares), RDX-grown cells treated with 150 µM RDX (closed 
diamonds). Expression level of gyrB (endogenous control) was the same in all of the conditions. 
Error bars show one standard deviation for four samples.   
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5.3.3.2 Putative promoter prediction of the xplA operon  
To investigate the presence of putative promoter regions in the gene cluster, sequence 
from ORF 27 to ORF 32 (Figure 5.26) was analysed by softberry-BPROM, a bacterial 
promoter prediction software programme 
(http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfin
db). Two putative promoter regions were predicted. These putative promoters are 
located upstream of the putative permease (ORF 29) and upstream of xplB (Figure 
5.26).  The exact locations of these two putative promoters on the gene cluster are 
shown in Figure 5.27 and 5.28.   
 
 
 
 
Figure 5.26. The RDX degrading gene cluster in strain 11Y. The predicted putative promoter 
regions were presence upstream of the putative permease (ORF 29) and the xplB (ORF 31).  
 
 
 
 
 
 
 
 
 
 
 
ORF 27          ORF 29                  ORF 30              ORF 31                  ORF 32                    
xplA       xplB       permease       
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gtgacgaacgacgatctggtgcaccggctgcgttcgctgaccgtcgaactcgatgtcttc 
 M  T  N  D  D  L  V  H  R  L  R  S  L  T  V  E  L  D  V  F  
 
ggggccggcttcgccgcccgaaacgggttgcacgccaccgatgtacgtgccctgatcgct 
 G  A  G  F  A  A  R  N  G  L  H  A  T  D  V  R  A  L  I  A  
 
cttctggaccgggatcgggccggcgccgtcgcctctcctgggtggctggcggggcatctc 
 L  L  D  R  D  R  A  G  A  V  A  S  P  G  W  L  A  G  H  L  
 
ggactcaacagtgcgtcgaccaccgcgctcatcgatcgactggaatcgaagggtctggtg 
 G  L  N  S  A  S  T  T  A  L  I  D  R  L  E  S  K  G  L  V  
 
gaccgcaggcgcgacgactcggatcgtcgccgggttgcgctgcacgtcaccgacgcggcc 
 D  R  R  R  D  D  S  D  R  R  R  V  A  L  H  V  T  D  A  A  
 
caggagatgggctggaccttcttcgggccgttgatcgaccaggtgatcgcggtggccgac 
 Q  E  M  G  W  T  F  F  G  P  L  I  D  Q  V  I  A  V  A  D  
 
ggtttctccgacgacgaactgaccacgatccgcacatttctggaccaggtcaccgctgcg 
 G  F  S  D  D  E  L  T  T  I  R  T  F  L  D  Q  V  T  A  A  
 
gtggcgggagtccggacccgctgagtgtcctgggtccgcagccgctgaccctgtccgcac 
 V  A  G  V  R  T  R  -  
 
accgctcacctcagggtcgaaccggagccgtccgcccgatggttaccggaacatgaccat 
 
tgttaattctgcgttccggcctggcgtcaaaaaaccctatgtttgtagtatttggcgaaa 
 
tccgtttggcgtcaggagattcaggcatggccacgacgaatgtgtatccgacagacgagg 
 
gggtcccggaccgggacgcccagatgctggccgaactcggttatacgtccgaattcaaac 
 
gggagatgagtccgtgggcgaacttcgccctcggcttcacctacctgtcgcccgtcgtc 
       M  S  P  W  A  N  F  A  L  G  F  T  Y  L  S  P  V  V  
    
gggatctacacggtcttcgcctatgcgatggcacaggccggcccgccgatgatctggagc 
 G  I  Y  T  V  F  A  Y  A  M  A  Q  A  G  P  P  M  I  W  S   
 
ctcgtcatcgtgggcctcgggcagttcctggtggcgctgatcttcagcgaggtcgtcgcc 
 L  V  I  V  G  L  G  Q  F  L  V  A  L  I  F  S  E  V  V  A   
 
cagttcccggtcgcggggggcgtgtatccgtggacacgccgactctggggccggaagtac 
 Q  F  P  V  A  G  G  V  Y  P  W  T  R  R  L  W  G  R  K  Y   
 
 
Figure 5.27. Nucleotide and amino acid sequence of MarR-like regulator (ORF 27) and 
initial part of the putative permease (ORF 29). Start (gtg or atg) and stop (tga) codons are 
shown in bold. The first putative promoter regions (-10 and -35) in upstream of the putative 
permease is shown in boxes.  
    
 
-10 P1  -35 P1  
(ORF 27)  
(ORF 29)  
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atgacgaacatcagagctgtcgtgtacggcgtcggagcgatgaactccgtgatcacccgc 
 M  T  N  I  R  A  V  V  Y  G  V  G  A  M  N  S  V  I  T  R  
 
tatctgctcgacaaggacgtcgagatcgtaggcgccatctcgcgcagtccggacaaggtg 
 Y  L  L  D  K  D  V  E  I  V  G  A  I  S  R  S  P  D  K  V  
 
ggcaaggacctcggcgaggtcaccggactcgaccgtcgactcggagtgtcgatcagcgac 
 G  K  D  L  G  E  V  T  G  L  D  R  R  L  G  V  S  I  S  D  
 
gacccgcacgaggtgttcacgcggacgagtcccgacatcgcggtcgtcgcgatcaccagc 
 D  P  H  E  V  F  T  R  T  S  P  D  I  A  V  V  A  I  T  S  
 
tatctcgtggacgccgcggagcacttccgtatcgcactgtcgcacggggtcaacgtgatc 
 Y  L  V  D  A  A  E  H  F  R  I  A  L  S  H  G  V  N  V  I  
 
acgctgtccgaggaagcgctctatccctggaacaccgcgcccgaactgaccgcggaactc 
 T  L  S  E  E  A  L  Y  P  W  N  T  A  P  E  L  T  A  E  L  
 
gatgcactcgccaaggagcatggcgtgaccatcacgggcgggggtttccaggacagcttc 
 D  A  L  A  K  E  H  G  V  T  I  T  G  G  G  F  Q  D  S  F  
 
tgggtgaacgcggtcgcccagctgatgggcacggcacaccgcatcgactcggtcaccggg 
 W  V  N  A  V  A  Q  L  M  G  T  A  H  R  I  D  S  V  T  G  
 
acgagttcgtggaacgtcgacgagtacggcccggaactggccgagctgcagcaggtcggc 
 T  S  S  W  N  V  D  E  Y  G  P  E  L  A  E  L  Q  Q  V  G  
 
gcgacgatcgaggagttcgacgcctggtgccgagaagccgtgcgtccgcccacattcggc 
 A  T  I  E  E  F  D  A  W  C  R  E  A  V  R  P  P  T  F  G  
 
cggatcgctctcgatgcgctggtcgccggagcggggctgacgcccaagcagatcctgacg 
 R  I  A  L  D  A  L  V  A  G  A  G  L  T  P  K  Q  I  L  T  
 
cgcaccgaacccgaactggcacacgagactctgcactgtgctgccctggggatcgacgtc 
 R  T  E  P  E  L  A  H  E  T  L  H  C  A  A  L  G  I  D  V  
 
ccgccgggaaagtgcatcggcttcaccgacatcgacgagatccgcacggaagagggcccg 
 P  P  G  K  C  I  G  F  T  D  I  D  E  I  R  T  E  E  G  P  
 
gtcttcgtcttccggatgtccggccggctgtacggccccgacgacagcgatgtcaacgaa 
 V  F  V  F  R  M  S  G  R  L  Y  G  P  D  D  S  D  V  N  E  
 
tggacgatccacggcgaacccgatctggtgatgtccaacggcaccccgccgacgatggcc 
 W  T  I  H  G  E  P  D  L  V  M  S  N  G  T  P  P  T  M  A  
 
accacctgcacccaattggtgaaccgtatccccgacgtgctcgacgccgacccgggattc 
 T  T  C  T  Q  L  V  N  R  I  P  D  V  L  D  A  D  P  G  F  
 
gtgaccgtcgtcgatctgcccaggctgcgctaccggcacggtcggctgcacgaccacctg 
 V  T  V  V  D  L  P  R  L  R  Y  R  H  G  R  L  H  D  H  L  
 
agcaggtggtcatcggatcgttacatcgtgcgcgaagaactgtaacaatagatggacatc 
 S  R  W  S  S  D  R  Y  I  V  R  E  E  L  -        M  D  I  
(ORF 30)  
(ORF 31)  -10 P2  -35 P2  
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atgagtgaagtggacgtggcaccgcgcgtggcggtggtcggcgcgggaccgtcgggttgt 
 M  S  E  V  D  V  A  P  R  V  A  V  V  G  A  G  P  S  G  C   
 
ttcaccgcacagcaactccgcaagcagtggccggaggtggaggtcaccgtcttcgaccgg 
 F  T  A  Q  Q  L  R  K  Q  W  P  E  V  E  V  T  V  F  D  R   
 
ctacccaccccgttcgggctccttcgctacggcgtggctcccgaccatcagggcacgaag 
 L  P  T  P  F  G  L  L  R  Y  G  V  A  P  D  H  Q  G  T  K   
 
 
Figure 5.28. Nucleotide and amino acid sequence of the putative dihydrodipicolinate 
reductase (ORF 30) and initial part of the xplB (ORF 31). Start (atg) and stop (taa) codons 
are shown in bold. The second putative promoter regions (-10 and -35) in upstream of the xplB 
is shown in boxes.  
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5.3.3.3 Sequence analysis of the MarR-like regulator in 11Y 
A multiple alignment of the 11Y putative MarR-like regulator and its homologues is 
shown in Figure 5.29. The 11Y regulator was found to share 100 % amino acid identity 
with the Microbacterium sp. MA1 regulator and 62 % amino acid identity with a putative 
regulator from Gordonia bronchialis DSM 43247. The other Rhodoccoccal regulator 
described in Fig. 5.29 shared more than 50 % amino acid identity with the MarR 
regulator from strain 11Y. A conserved (helix-turn-helix) domain was detected in the 
amino acid sequence of the putative 11Y regulator (amino acid residues 52 to 127) by 
two sequence analytical programmes: blastp (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
and Interprot scan (http://www.ebi.ac.uk/Tools/pfa/iprscan/).    
 
Figure 5.29. The alignment of MarR-like regulator of 11Y with its homologues. 
Abbreviations: (SK121) Rhodococcus erythropolis SK121, (PR2) Rhodococcus erythropolis 
PR2, (REATTC) Rhodococcus equi ATCC 33707, (RE103S) Rhodococcus equi 103S, (RR11Y) 
Rhodococcus rhodochrous 11Y, (MMA1) Microbacterium sp. MA1, (GBDSM) Gordonia 
bronchialis DSM 43247. The helix-turn-helix domain is indicated with bar. The identical amino 
acid residues are indicated with *.    
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The organisation of the XplA gene cluster in strain 11Y suggests that the genes on the 
cluster are regulated by the MarR-like transcriptional regulator (ORF 27). To investigate 
whether the putative regulator is controlling xplA expression, the putative regulator was 
deleted. Characterisation of the putative transcriptional regulator knockout is described 
in the following sections.    
 
5.3.3.4 RDX removal by whole cells of RDX-grown regulator 
knockout strain 
Early (OD600 ~0.3) and late (OD600 ~0.8) log stages of regulator knockout and wild-type 
cells were used in resting cell assays to monitor RDX degradation over the incubation 
time. Cells were incubated in RDX minimal medium at room temperature for 1 hour.  
Results (Table 5.3) showed similar amount of RDX removal in the knockout and WT 
strains. 
 
Table 5.3. Resting cell assays for regulator knockout and wild-type strains. Cells 
(0.02 g/mL) were incubated in minimal medium containing 150 µM RDX as a sole 
nitrogen source. Samples were taken at interval time of 10 min and 20 min. Results 
represent the averages of percentage RDX removal (standard deviation) of triplicate 
samples. 
    
 
 
        
 
 
 
      Strains           Percentage of RDX removal  
  
                                                 Early log stage cells          Late log stage cells 
 
                                                  10 min      20 min              10 min        20 min                                          
       
         
        WT                                   26.9 (0.6)   37.8 (0.4)         35.6 (1.1)    57.4 (2.3)     
        Regulator KO                   26.7 (0.4)   37.9 (0.5)         32.7 (0.9)    63.6 (1.3) 
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5.3.3.5 RDX removal by the regulator knockout strain exposed 
to different nitrogen sources  
As described in section 5.3.3.1, the wild-type strain of 11Y exposed to nitrogen-limiting 
and nitrogen-starving conditions resulted in increased of RDX degrading activity 
compared to that found in cells grown in a range of alternative nitrogen sources. To 
investigate whether the regulator knockout has a similarly enhanced level of RDX 
degradation when exposed to these conditions, the knockout and wild-type strains 
were treated under following conditions (Table 5.4). 
 
Table 5.4. Growth and treatment media. Cells (0.1 mg/mL) were inoculated into the 
growth medium (700 mL) and incubated at 30 °C with shaking (180 rpm) for 17 hours. 
After the harvesting of cells, same amount of cells (2 mg/mL) were transferred into the 
treatment medium (250 mL) for 3 hours incubation. After the treatment, cells were used 
for resting cell experiments.  
 
 
 
 
 
 
 
 
 
 
 
(a) 750 µM KNO2   450 µM KNO2   
(b) 5 mM KNO3   5 mM KNO3   
3 hours treatment   Growth medium   
(c) 750 µM KNO3   No nitrogen (starving)   
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Resting cell assays demonstrated that the RDX removal rates in the regulator knockout 
were lower than wild-type when treated with nitrite (450 µM) and nitrate (5 mM). There 
was no difference in the degradation rates when both wild-type and the regulator 
knockout strains were treated with medium that contained no nitrogen source (Fig. 
5.30).   
 
Figure 5.30. RDX removal by the regulator knockout and wild-type strains. KNO2-grown 
cells treated with 450 µM KNO2 (WT-closed triangles; knockout-closed diamonds). KNO3-grown 
cells treated with no nitrogen medium (WT-open circles; knockout-closed squares). KNO3-grown 
cells treated with 5 mM KNO3 (WT-open squares; knockout-open triangles). Error bars show 
one standard deviation for duplicate samples.  
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5.3.3.6 A comparison of RDX degradation and growth of the 
wild-type and regulator knockout strains in the presence of 
alternative nitrogen sources  
Studies have shown that RDX degradation by whole cells was delayed in the presence 
of alternative nitrogen sources (Nejidat et al., 2008, Jung et al., 2011). To investigate 
whether the RDX degradation in the wild-type and regulator knockout strains is also 
affected by the presence of alternative nitrogen sources, growth experiments were 
performed with different nitrogen sources.  
Cells were grown in minimal medium contained RDX only or RDX with additional 
nitrogen sources (nitrite/nitrate) and RDX degradation was monitored over the 
incubation time. For the wild-type strain, RDX was degraded at the fastest rate when 
no alternative nitrogen source was supplemented in the medium, with 91 % of RDX 
removal after 12 h of incubation (Fig. 5.31). The presence of alternative nitrogen 
sources delayed the RDX degradation in wild-type. In the presence of KNO3 or NaNO2, 
approximately 59 % and 49 % of the RDX was degraded, respectively, within 12 hours 
after inoculation.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.31. Effect of nitrogen on RDX degradation in strain 11Y wild-type. RDX alone 
(closed triangles), supplemented with 5 mM of KNO3 (open squares) and NaNO2 (closed 
diamonds). Error bars show one standard deviation for duplicate samples. 
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The growth of wild-type cells was monitored by measuring the optical density (OD) at 
600 nm. While cells in medium containing RDX-only and RDX supplemented with nitrite 
grew at a similar rate, cells in medium containing RDX supplemented with nitrate grew 
faster (Figure 5.32).   
 
Figure 5.32. Growth profile of strain 11Y wild-type. RDX alone (closed triangles), 
supplemented with 5 mM of KNO3 (open squares) and NaNO2 (closed diamonds). Error bars 
show one standard deviation for duplicate samples. 
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The effect of nitrite and nitrate on RDX degradation by the regulator knockout strain 
was found to be similar to wild-type (Fig. 5.33).   
 
 
Figure 5.33. Effect of nitrogen on RDX degradation by growing cells of the regulator 
knockout strain. RDX-alone (closed diamonds), supplemented with 5 mM of KNO3 (open 
triangles) and NaNO2 (closed triangles). Error bars show one standard deviation for duplicate 
samples. 
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While the regulator knockout in medium containing RDX-only and RDX supplemented 
with nitrite grew at similar rates, cells in medium containing RDX supplemented with 
nitrate grew slightly faster (Figure 5.34).   
 
 
 
Figure 5.34. Growth profile of the regulator knockout. RDX alone (closed diamonds), 
supplemented with 5 mM of KNO3 (open triangles) and NaNO2 (closed triangles). Error bars 
show one standard deviation for duplicate samples. 
 
When the RDX degradation rates of both wild-type and putative regulator knockout 
strains, grown in medium containing the same nitrogen sources (RDX-only, RDX + 
KNO3 or RDX + NaNO2), were compared, a similar RDX degradation rate was 
observed to that grown in medium contained RDX-only (Fig. 5.35A). However, in 
medium containing RDX + KNO3 and RDX + NaNO2, the RDX degradation rate for the 
knockout strain was slower than wild-type (Fig 5.35B and C).  
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Figure 5.35. Comparison of RDX degradation between regulator knockout and wild-type 
strains. Strains 11Y WT (closed triangles) and regulator knockout (open triangles) were 
incubated in minimal medium contained different nitrogen source: (A) RDX-alone, (B) RDX and 
KNO3, (C) RDX and NaNO2. Initial concentration for RDX and other nitrogen sources (KNO3 or 
NaNO2) was 150 µM and 5 mM, respectively. Error bars show one standard deviation for 
duplicate samples. 
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5.4 Discussion 
A total of four gene knockouts of R. rhodochrous 11Y (MarR-like regulator, permease, 
xplB and xplA) were successfully constructed using an unmarked gene deletion system 
(van der Geize 2001). The mutagenic plasmids were transferred into the genome of 
strain 11Y by conjugation, and following selection stages, gene deleted strains were 
obtained. There are fewer tools available to manipulate the DNA in Gram-positive 
bacteria compared to E. coli. This unmarked gene deletion system is one of the most 
efficient systems to delete a gene from the genome of Gram-positive bacteria and 
successful cases of the gene deletion using the same approach in Rhodococcus spp. 
have been reported (Yang et al., 2007, Rosloniec et al., 2009, Okamoto et al., 2010, 
Wilbrink et al., 2011). 
The genus Rhodococcus is well known to have the ability to metabolise broad range of 
organic compound, such as naphthalene (Kulakov et al., 2005), polychlorinated 
biphenyl (Seto et al., 1995), atrazine (Behki et al., 1993, Shao et al., 1995) and RDX 
(Fournier et al., 2002, Seth-Smith et al., 2008). Multiple transformation systems for 
PCB degradation in Rhodococcus strain RHA1 have been reported (Seto et al., 1995). 
Besides this, multiple homologues of alkane hydrolase and extradiol dioxygenase have 
also been identified in Rhodococcus strain Q15 and Rhodococcus sp YK2, respectively 
(Whyte et al., 2002, Iida et al., 2002). To investigate whether xplA is the sole RDX 
degrading gene in Rhodococcus strain 11Y, this gene was deleted, and the resulting 
xplA knockout characterised. The xplA deleted strain was unable to degrade RDX in 
liquid medium in growth and resting cell experiments showing that XplA is the only 
RDX degrading gene presence in strain 11Y.  
When grown on RDX dispersion agar, a defined zone of clearance was observed 
around colonies of the wild-type strain and these were not seen when the xplA 
knockout strain was grown on similar medium (Figure 5.16). This shows that XplA 
activity is directly linked to the zone of clearance formation mechanism. While RDX is 
being degraded by XplA within 11Y, a gradient diffusion of RDX through the 
surrounding agar occurs. This leads to solubilisation of insoluble RDX and thus a zone 
of clearance around the colonies develops.   
Recombinant XplB has been shown to transfer electrons from NADPH to XplA for RDX 
degradation (Jackson et al., 2007). It was therefore not surprising that the xplB 
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knockout strain showed reduced RDX activity when compared to the wild-type in 
growth and resting cell experiments. But, that some XplA activity is retained in the xplB 
knockout suggests that XplA is able to obtain reducing equivalents from another 
source. Heterologous and homologous expressions of xplA without xplB, into non-RDX 
degraders (E.coli, R. rhodochrous CW25 and R. jostii RHA1) are able to degrade RDX 
in vivo (Seth-Smith et al., 2002, Jackson et al., 2007, Indest et al., 2010). This indicates 
that one or more surrogate reductases, that can partner XplA for RDX activity, are 
present in the non-RDX degraders. Importantly, this also demonstrates that the transfer 
of xplA alone from donor to recipient naturally in the microbial environment is sufficient 
for the recipient to acquire the ability to degrade RDX.  
In bacteria, genes encoding related functions are frequently situated close to each 
other (Williamson et al., 2006, Yu et al., 2007). The putative permease (ORF 29) 
located upstream of the xplA/B genes cluster in strain 11Y was speculated to be 
involved in the transport of RDX. Characterisation of the permease knockout strain 
showed no differences in RDX removal in both growth experiments and resting cell 
assays when compared with the wild-type, implying that there might be more than one 
transporter involved in the uptake of RDX. It is reported that L-lactate permease (LldP) 
and glycolate permease (GlcA) in E. coli are able to take up the 2-
hydroxymonocarboxylic acid substrates (Nunez et al., 2002). A second example is the 
succinate transport system in Rhizobium tropici CIAT899 (Batista et al., 2009). An 
insertion mutant of the first succinate transporter (DctA permease) was unexpectedly 
able to use succinate as a sole carbon source (Batista et al., 2001). The second 
succinate transporter (KgtP permease) was uncovered by Tn5 mutagenesis of dctA 
mutant.   
Sequence analysis indicates that ORF 29 encodes a putative transporter with 
homology to the amino acid permease from Mycobacterium vanbaalenii PYR-1, with 76 
% sequence identity. (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Transmembrane helix 
prediction using software TMHMM Server version 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) showed twelve transmembrane helices 
present in this putative transporter. Based on sequence analysis, the permease in 11Y 
might be involved amino acid transport. Uncharacterised ORF 30 (Fig. 5.26), which 
located in between the putative permease (ORF 29) and xplB (ORF 31) of the strain 
11Y RDX gene cluster, encodes a putative dihydrodipicolinate reductase. This 
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reductase has been shown to be involved in the L-lysine biosynthesis pathway and the 
initial substrate of the pathway is L-aspartate (Rodionov et al., 2003). Therefore, it 
would be interesting to investigate the role of the putative permease in transport of L-
lysine and L-aspartate in strain 11Y. Due to time limitations, studies investigating the 
putative permease as L-lysine and L-aspartate transporter were not carried out.   
An investigation into the regulation of xplA demonstrated that a basal level of XplA was 
produced when cells were grown in medium containing excess nitrogen (5 mM KNO3). 
The XplA activity was further induced by nitrogen-limiting (450 µM KNO2 or KNO3) and 
starving (no nitrogen) conditions. So far, there is no record in the literature reporting 
that XplA activity could be induced by low nitrogen availability in the medium. The 
presence of RDX (conditions (e) and (f) in Table 5.2) further induced the XplA activity. 
The XplA activity assays in cell free extracts and western blot analysis are in 
agreement with the result of the resting cell experiments. Collectively, these findings 
confirmed RDX is able to act as an inducer for XplA expression in strain 11Y. 
Palindromic sequences have been found in the upstream of haloalkane dehalogenase 
(dhaA) and an ATPase (ParA) genes in Rhodococcus spp. (Kulakova et al., 1997, De 
Mot et al., 1997). Generally, the presence of palindromic sequence could lead to the 
hairpin formation of the DNA and allow regulator to interact with the DNA, resulting in 
the repression or activation of the transcription (Perera and Grove, 2010). Sequence 
analysis of the promoter regions in 11Y failed to identify any palindromic sequences 
(http://www.biophp.org/minitools/find_palindromes/demo.php). Two putative promoter 
regions were located within the RDX degrading gene cluster in strain 11Y (Fig. 5.26) 
which implies that more than one type of regulation mechanisms could be involved in 
controlling XplA expression. In resting cell assays (Figure 5.22), two types of XplA 
induction were observed, one in which the XplA expression is induced by the low 
nitrogen availability conditions and RDX. Bioinformatic analysis of the Gordonia sp. 
RDX degrading gene cluster revealed only one putative promoter (Indest et al., 2010).  
In the presence of high concentrations of nitrite or nitrate (5 mM), RDX degradation in 
11Y wild-type was reduced when compared to when RDX only was present in the 
medium (Section 5.3.3.6). Similar results were observed in Rhodococcus strain YH1 
(Nejidat et al., 2008) and Gordonia strain KTR9 (Indest et al., 2010), suggesting a 
similar RDX regulation system is present in these RDX degrading bacteria.  
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Sequence analysis suggests that the putative transcriptional regulator (ORF 27) in the 
11Y gene cluster is a MarR-like regulatory protein, a multiple antibiotic resistance 
regulator in Gordonia bronchialis DSM 43247 (protein ID: 62 %). MarR, probably 
amongst the best characterised regulator protein from MarR family, is a repressor that 
controls the gene expression of multiple antibiotic resistant marAB operon in E. coli 
(Alekshun and Levy, 1997). Structural studies have revealed that salicylate is able to 
complex with MarR (Alekshun et al., 2001), which is unable to bind to the operator 
region of marAB and allows transcription. Many other MarR-type regulators are also 
reported to be negative regulators (Park and Kim, 2001, Fuangthong et al., 2001, 
Providenti and Wyndham, 2001, Wilkinson and Grove, 2005). Few of them are found to 
be activators. BadR from Rhodopseudomonas palustris is one example (Egland and 
Harwood, 1999). It is interesting to observe that the RDX removal rates of the regulator 
knockout were slower than wild-type whether they were treated with a low (450 µM) or 
high concentration of nitrate (5 mM) (Fig. 5.30). Additionally, section 5.3.3.6 
demonstrated that the presence of nitrate or nitrite in the medium delayed the RDX 
degradation in the regulator knockout compared to wild-type (Figure 5.35). These hint 
that the MarR-like regulator in 11Y could be acting as a positive regulator in controlling 
the xplA expression in 11Y. Since these are preliminary studies, further 
characterisation of this regulator is necessary to understand in more detail how it 
controls the gene cluster and is integrated in the regulation of central nitrogen 
metabolism in 11Y. The future works of this regulator are discussed in final discussion 
chapter.     
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Chapter 6 
6.1 Final discussion 
The members of the genus Rhodococcus are able to degrade a broad range of organic 
compounds (Behki et al., 1993, Seto et al., 1995, Seth-Smith et al., 2002, Whyte et al., 
2002, Larkin et al., 2005, Kulakov et al., 2005, Bernstein et al., 2011). To date, 
Rhodococcus spp. appear to be the majority of RDX degrading bacteria. The goal of 
this study was to gain a better understanding on the biodegradation of RDX in 
Rhodococcus spp., specifically exploring the RDX degradation in Rhodococcus 
erythropolis strain HS4 and analysis of the RDX degrading gene cluster in 
Rhodococcus rhodochrous strain 11Y.  
The Rhodococcus erythropolis strain HS4 was previously found to be able to degrade 
RDX and its RDX degrading system was characterised as cytochrome P450 system by 
metyrapone, a P450 inhibitor. However, no xplA and xplB homologues were detected 
by both Southern blot analysis (Seth-Smith et al., 2008) and PCR (using primers 
specific to these genes described in Chapter 3), suggesting this strain could potentially 
possess an alternative RDX degrading P450. An attempt to purify the protein of interest 
in HS4 using affinity purification was not successful. Although earlier western blot 
analysis using XplA antibody revealed a band at the molecular weight of 58 kDa, the 
band was later confirmed to be an artefact and was also detected in cell free extracts of 
Rhodococcus CW25, a non-RDX degrading bacterium. The most recent studies on 
HS4 have revealed that it has lost its ability to degrade RDX, possibly encoded on a 
similar plasmid to that known to contain xplA/B in other strains of Rhodococci. Due to 
the loss of RDX degrading activity in HS4, the investigation on this strain was not 
continued. The isolation of new RDX degrading gene(s) is an area of particular interest 
as other RDX strains are likely to exist. Stenotrophomonas maltophilia PB1 was the 
only reported Gram-negative RDX degrading bacterium (Binks et al., 1995). When PB1 
cell free extracts was incubated with RDX in phosphate buffer, RDX degrading activity 
was detected. Unlike strain 11Y, reductase and cofactor recycling system were not 
required to detect RDX degrading activity in PB1 cell free extracts. This suggests that 
the RDX degrading system in strain PB1 could be different from XplA/B system in 
strain 11Y.      
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 Figure 6.1. XplA/B gene cluster in R. rhodochrous 11Y. 
 
At present, two distinct plasmid-encoded gene clusters flanking with the xplA and xplB 
have been successfully found (Andeer et al., 2009, Indest et al., 2010). The gene 
cluster from Microbacterium sp. MA1 contains nine open reading frames (ORF) 
including two transposases (Figure 1.11). The other gene cluster is from Gordonia sp., 
which has four open reading frames (Figure 1.12). Bioinformatics revealed that the 
RDX degrading gene cluster in strain 11Y is nearly identical (>99.8 % amino acid 
identity) to the gene cluster from Microbacterium sp. MA1, with the exception of the 
transposases (ORF 28 and 35), which were absent in the 11Y gene cluster (Figure 
6.1). Interestingly, recent sequence comparisons of the RDX degrading clusters in RDX 
degrading Rhodococcus spp. that were isolated from geographically distinct location 
(Belgium, UK and Australia) revealed more than 99.8 % amino acid sequence identity 
to the 11Y gene cluster (Dana Sabir, personal communication). The finding suggests 
the gene cluster may have been transferred via the horizontal gene transfer prior to its 
global distribution. Recently studies demonstrated the pGKT2 containing xplA/B gene 
cluster could be transferred by conjugation (Jung et al., 2011). Of 26 recipients, pGKT2 
was successfully transferred from Gordonia sp. KTR9 to Gordonia polyisoprenivorans, 
Rhodococcus jostii RHA1 and Nocardia sp. TW2, conferring the recipients the ability to 
degrade RDX and to utilise RDX as a sole source of nitrogen.   
Heterologous expression of the rhodococcal permease in E. coli successfully resulted 
in this protein being incorporated in the membrane, which was confirmed by peptide 
mass fingerprinting. Cells of E. coli Rosetta 2 were found to be able to express the 
permease; however, whole cell uptake assays did not show higher RDX uptake in the 
permease-expressing clone compared to the control (non-expressing clone). A 
xplA xplB permease      MarR 
 156 
permease deleted strain derived from Rhodococcus strain 11Y was constructed using 
the unmarked gene deletion system. Characterisation of this knockout strain including 
growth experiments, resting cell assays and western blot analysis revealed no 
significant difference in comparison to the wild-type. More than one type of transporters 
can be involved in uptake of the same substrate in bacteria (Batista et al., 2001, Nunez 
et al., 2002, Batista et al., 2009). However, to prove if the 11Y permease is the RDX 
transporter, the in vitro RDX uptake assays would need be performed using the 
constructed proteoliposomes. Although the transporter of RDX in strain 11Y remains 
unknown, by using a Tn5-based random mutagenesis approach may help to identify 
the RDX transporter (Fernandes et al., 2001).   
The xplA knockout lost its ability to degrade RDX suggesting XplA is the only enzyme 
that degrades RDX in 11Y. The xplB knockout confirmed XplA could obtain reducing 
equivalents from another source. Perhaps this is not surprising as a total of three 
reductases were found in the genome of Rhodococcus sp. RHA1 (McLeod et al., 
2006). Also, expression of XplA in non-RDX degrading bacteria (E. coli and 
Rhodococcus spp.) and plants (Arabidopsis) demonstrated RDX degrading activity, 
indicating the flexibility of XplA to partner other reductase(s) for RDX activity (Rylott et 
al., 2006, Indest et al., 2010).  
An investigation into the regulation of xplA in strain 11Y was performed. Resting cell 
experiments using the wild-type strain revealed that the basal XplA activity was 
detected in excess nitrogen medium. XplA activity found to be induced in nitrogen-
limiting or no nitrogen medium, and the activity further enhanced by RDX. Growth 
experiments of the wild-type cells also showed that RDX degradation in medium 
containing excess nitrogen was delayed when compared to cells were growing in RDX 
only medium. These findings imply that xplA expression in 11Y is regulated and the 
regulation is linked to the central nitrogen metabolism in 11Y. Nitrogen control in 
Rhodococcus spp. has not been well studied to date; however, the general patterns of 
nitrogen metabolism and regulation in Gram-positive bacteria has been reviewed by 
Amon and co-workers (2010). The regulatory network of nitrogen metabolism in 
Corynebacterium sp., a close related bacterium to Rhodococcus strain 11Y, revealed 
the involvement of a global nitrogen regulator (AmtR).  
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AmtR-DNA binding studies demonstrated 35 nitrogen genes are directly regulated by 
AmtR in Corynebacterium glutamicum (Jakoby et al., 2000, Beckers et al., 2005, 
Buchinger et al., 2009, Amon et al., 2010). Some examples of these genes are glnK, 
encoding nitrogen regulatory protein PII, gltB, encoding glutamate synthase, ureC, 
urease alpha subunit and amtA, encoding an ammonium transporter. Based on the 
AmtR consensus motif of Corynebacterium sp. (ATCTATAGN1-4ATAG) (Burkovski, 
2003), homologues of putative AmtR binding sites on 11Y gene cluster were found. 
These putative binding sites were located on -10 boxes of the putative promoter 
regions of the gene cluster: AaCccTAtN4gTAG (upstream of permease) and 
AaCTgTAaN2ATAG (upstream of xplB), with 3-5 nucleotides differences compared to 
the AmtR consensus motif of Corynebacterium sp (nucleotides differences marked with 
lower case + underline).  
The MarR-like knockout strain when previously exposed to nitrogen-excess or limiting 
conditions degraded RDX more slowly than the wild-type cells in whole cell 
experiments. Also, growth experiments performed in medium containing RDX plus 
nitrite/nitrate demonstrated the RDX degradation in the MarR-like knockout strain was 
slower compared to wild-type. These findings imply that the putative 11Y regulator 
could be positively regulating the xplA expression in 11Y. Although the majority of the 
MarR-like regulators are repressors, there have been a few reports where these 
proteins have been shown to be activators. RosR, a MarR-like regulator controls 
multiple genes in Corynebacterium sp. (Bussmann et al., 2010), as a repressor for 
genes encoding monooxygenase and glutathione S-transferases and, as an activator 
for genes encoding the putative nitrate/nitrite transporter and nitrate reductase. Since 
two putative promoter regions were identified on the RDX degrading cluster in 11Y, 
electrophoretic mobility shift assay (EMSA) could be carried out to identify if these 
regions are able to interact with the 11Y MarR. The role of MarR in regulating genes in 
11Y can be further investigated by comparing the global gene expression between the 
MarR knockout and wild-type by DNA microarray experiments. Genes that are up or 
down-regulated can be identified and EMSA will confirm the role of MarR in controlling 
these genes in 11Y.  
The regulation of herbicide atrazine - degradative genes (atrR-atrDEF) in 
Pseudomonas sp. strain ADP (Govantes et al., 2010) was found to be similar to the 
regulation of RDX degrading genes in Rhodococcus strain 11Y. The Pseudomonas sp. 
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strain ADP is able to use atrazine as the sole nitrogen source (Garcia-Gonzalez et al., 
2003). The atrazine degradation using whole cells, which was previously grown in rich 
nitrogen medium, was inhibited. Efficient atrazine degradation in the strain was 
observed when using cells previously grown under nitrogen-limiting conditions, on 
atrazine or on an intermediate product of atrazine degradation cyanuric acid. The 
regulatory network of atrazine degradation that integrates to the central nitrogen 
metabolism in Pseudomonas sp. has recently been described (Hervas et al., 2008, 
Govantes et al., 2010). The transcription of atzR, encoding a regulator that controls the 
atrazine gene cluster (atrDEF), is activated by a global nitrogen regulator NtrC. AtzR 
activates atrDEF transcription when two type of signals are sensed: cyanuric acid and 
nitrogen limitation, by a PII signal transduction protein (GlnK), resulting in expression of 
genes on the cluster (atrDEF). Based on the similar induction pattern between atrazine 
and RDX activities in the whole cell assays, it is possible that the regulation of RDX 
degradation in 11Y is similar to the regulation of atrazine degradation. It would be 
interesting to investigate the regulatory network for RDX degradation that links this to 
the central nitrogen metabolism in strain 11Y. The genes involved in the regulatory 
network for example a global nitrogen regulator and PII signal transduction protein 
could be identified and their role in xplA regulation in 11Y investigated.  
The key finding in this study was that the RDX degrading activity in whole cells was 
induced by nitrogen-limiting conditions and further induced by RDX. This information is 
particularly useful for the remediation of RDX contaminated areas. Efficient biological 
treatment of RDX contaminated sites could be achieved by optimising the treatment 
parameters, which one of them is the nitrogen levels at the treatment site (e.g. 
adjusting the nitrogen levels at the treatment site). Isolation of RDX degrading strains 
that are able to metabolise RDX efficiently under rich and low nitrogen conditions would 
be an area of particular interest as this strain could degrade RDX efficiently without 
being affected by the level of nitrogen.  
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Appendix A: Typical protein assay standard 
curve 
 
y = 0.0012x
R2 = 0.97
0
0.2
0.4
0.6
0.8
1
0 100 200 300 400 500 600 700 800
 Protein concentration (µg/mL)
Ab
so
rb
an
ce
 
(O
D
59
5)
 
 
 
 
 
 
 
 
 160 
 
Appendix B: Typical RDX standard curve 
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Appendix C: Typical nitrite standard curve 
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Appendix D: Sequencing analysis for knockouts  
A shorter PCR product was amplified in the gene-deleted strains. Sequencing analysis 
revealed that the gene (permease, regulator, xplA or xplB) in the knockout was deleted. 
The gene deleted sequence was indicated with dash (-). 
a) permease knockout 
TCTCGATTATCGAGAGACTAGATCATCGAGCGAAGTCGCGTACGGTGAACTCGTGACGAACGAC
GATCTGGTGCACCGGCTGCGTTCGCTGACCGTCGAACTCGATGTCTTCGGGGCCGGCTTCGCCG
CCCGAAACGGGTTGCACGCCACCGATGTACGTGCCCTGATCGCTCTTCTGGACCGGGATCGGGC
CGGCGCCGTCGCCTCTCCTGGGTGGCTGGCGGGGCATCTCGGACTCAACAGTGCGTCGACCACC
GCGCTCATCGATCGACTGGAATCGAAGGGTCTGGTGGACCGCAGGCGCGACGACTCGGATCGTC
GCCGGGTTGCGCTGCACGTCACCGACGCGGCCCAGGAGATGGGCTGGACCTTCTTCGGGCCGTT
GATCGACCAGGTGATCGCGGTGGCCGACGGTTTCTCCGACGACGAACTGACCACGATCCGCACA
TTTCTGGACCAGGTCACCGCTGCGGTGGCGGGAGTCCGGACCCGCTGAGTGTCCTGGGTCCGCA
GCCGCTGACCCTGTCCGCACACCGCTCACCTCAGGGTCGAACCGGAGCCGTCCGCCCGATGGTT
ACCGGAACATGACCATTGTTAATTCTGCGTTCCGGCCTGGCGTCAAAAAACCCTATGTTTGTAG
TATTTGGCGAAATCCGTTTGGCGTCAGGAGATTCAGGCATGGCCACGACGAATGTGTATCCGAC
AGACGAGGGGGTCCCGGACCGGGACGCCCAGATGCTGGCCGAACTCGGTTATACGTCC------ 
 
TAGCGACCATGACGAACATCAGAGCTGTCGTGTACGGCGTCGGAGCGATGAACTCCGTGATCAC
CCGCTATCTGCTCGACAAGGACGTCGAGATCGTAGGCGCCATCTCGCGCAGTCCGGACAAGGTG
GGCAAGGACCTCGGCGAGGTCACCGGACTCGACCGTCGACTCGGAGTGTCGATCAGCGACGACC
CGCACGAGGTGTTCACGCGGACGAGTCCCGACATCGCGGTCGTCGCGATCACCAGCTATCTCGT
GGACGCCGCGGAGCACTTCCGTATCGCACTGTCGCACGGGGTCAACGTGATCACGCTGTCCGAG
GAAGCGCTCTATCCCTGGAACACCGCGCCCGAACTGACCGCGGAACTCGATGCACTCGCCAAGG
AGCATGGCGTGACCATCACGGGCGGGGGTTTCCAGGACAGCTTCTGGGTGAACGCGGTCGCCCA
GCTGATGGGCACGGCACACCGCATCGACTCGGTCACCGGGACGAGTTCGTGGAACGTCGACGAG
TACGGCCCGGAACTGGCCGAGCTGCAGCAGGTCGGCGCGACGATCGAGGAGTTCGACGCCTGGT
GCCGAGAAGCCGTGCGTCCGCCCACATTCGGCCGGATCGCTCTCGATGCGCTGGTCGCCGGAGC
GGGGCTGACGCCCAAGCAGATCCTGACGCGCACCGAACCCGAACTGGCACACGAGACTCTGCAC
TGTGCTGCCCTGGGGATCGACGTCCCGCCGGGAAAGTGCATCGGCTTCACCGACATCGACGAGA
TCCGCACGGAAGAGGGCCCGGTCTTCGTCTTCCGGATGTCCGGCCGGCTGTACGGCCCCGACGA
Permease gene (ORF 29) was deleted 
Stop codon of MarR regulator (ORF 27) 
Start codon of dihydrodipicolinate reductase (ORF 30) 
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CAGCGATGTCAACGAATGGACGATCCACGGCGAACCCGATCTGGTGATGTCCAACGGCACCCCG
CCGACGATGGCCACCACCTGCACCCAATTGGTGAACCGTATCCCCGACGTGCTCGA 
 
b) MarR regulator knockout 
GAGAGAGCGCGGCCCGTCGGGGCCGCTTCGGTACGATCGTCCGAGTCTTCGGGAAACCGGCTCC
TGCGCAATACATCTGGGTCCACAGCGGTTCCGGGTCGGTCCCACGTGTCTCCCACGAGAGAAAC
CGTCGCAGACGCGGGGGAGTGGGCGCGATGAGCGTCGGGATGGCGTGCTGCAGATAGGCGATAC
GGAGTCCTGCGAAACACGATGTCGGGTCGAGCAGTGCCAGGTTGCGTACGCGAGCACCGTGTTG
CCCGGTCGCGAAGCCCAGCGCGATCATCGCGCCGTACGAGTGGCCGACGACGTCGACCGTGTCG
GTGGCCGCGGGATGGACGGCGATGTGGGCGCTGCTGATTGCGTCGGGGATCCGGTCGAGAACGG
CTGCGAGCCAGTCGAATAGCTCGGCGGGAGCTCGTGGGCTCGCAGCGCCGGGACGGGACCGTCC
GGCGTCGCCGAGGAGGTCGACGGCGATGACGTGGCGACCGGTCGCCAGGTGTTCCATGACGTTC
ACATACGACATCGACGTGGCTCCGCCGCCCGGCAAAAGGACCAGCGGCACGGCGTCGAGGGGCA
CGGCGTCGGGGGTGTCCGGGCGCGGCCCGATGATCGTGACCCGGGTGATGCCGTGCGCCGTCTC
GACATCGATCGGATGCCCTCCCGAGCGTGCGAGGAGCGCGTCGTAGGCGTCGAAAAACGCGATG
CCCTGCGGCGTGGCGGCGAAGACGTCGAGTGTCGGGC------TCAAAAAACCCTATGTTTGT 
 
AGTATTTGGCGAAATCCGTTTGGCGTCAGGAGATTCAGGCATGGCCACGACGAATGTGTATCCG
ACAGACGAGGGGGTCCCGGACCGGGACGCCCAGATGCTGGCCGAACTCGGTTATACGTCCGAAT
TCAAACGGGAGATGAGTCCGTGGGCGAACTTCGCCCTCGGCTTCACCTACCTGTCGCCCGTCGT
CGGGATCTACACGGTCTTCGCCTATGCGATGGCACAGGCCGGCCCGCCGATGATCTGGAGCCTC
GTCATCGTGGGCCTCGGGCAGTTCCTGGTGGCGCTGATCTTCAGCGAGGTCGTCGCCCAGTTCC
CGGTCGCGGGGGGCGTGTATCCGTGGACACGCCGACTCTGGGGCCGGAAGTACGCGTGGATGAC
GGGCTGGGTGTATCTGATCGCGCTGCTCGTCACCATCGGTTCGGTCGCCTACGGATCGGGGCCG
TTCATCGCGTCGCTCTTCGGCTACGAGGCGACCGCCTGGACCATCGCCCTGTGTGGTGTGGTGA
TGGTCGCCATCGCGACCGCCATCAACTTCCTCGGCACCAGGGTGGTCTCGGCGGCGGCCGTCTT
CGGTTTCGCCGCCGAGCTGATCGGCGCCCTCGTGGTCGGCGTGTATCTGATCGCCACACACCGG
CAGGTCGATCTGAGTGCCCTCTTCGACTCGTTCGGCGCCT 
 
 
MarR gene (ORF 27) was deleted 
Start codon of permease (ORF 29)  
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c) xplA knockout 
GTGCGCTCCACGCCCACCGACGCCAAGTTCGACCCGGTGATGATGCGTGAACTGGCGCACCTGG
CGTCGACGGAGTTCCGCCTCGCCGATGCGGGGGTGCTCGCCACGGCAGAGTCCTCCGACCCGCG
GAGTGCGGCCCTGGCCCACGTCGTCGAACGCGAGAGCCCGGCGGCACCGGCCACGACGGTGGTG
TTCCACTTCGGATCGACCCCGGTCGAGGTGATCGGCACCGACCGCGCGGAGGCCGTCAAGGTGC
GCACCGGCGTGCACACCACGACTCTCGCGTGCGACACCGTCATCACCGCAATCGGTTTCGAGTC
GGCCGTAAACGACGACCTCGACCTGACGCTGTACCGCGACGCCGATCCGGGAGAGGATTTTCTT
GCTCCGGGCCTGTACCGCACCGGGTGGCTGCACAGTTCCACCGGAGCGCTTCCCGAGATGCGGG
CCCGTGCCCGGGCGTTGGCGGCCCGAATCCGCCGCGATCATGCCGGTCACCATCCGGCCCGTCC
GGGTCTGGTGGCAATCCCTTACGAAGTGATCGACCGGACAGTCGATTTCGACGGCTGGATGCGG
ATCGACGAGGCGGAGGTCGCCTCGGCCTCGCCCGGCCGCATCCGGCAGAAGGTCCGCGAGGTCG
ACGCGATGCTGGCGTTGGCCCGCACCGTGCCGGCCGAATCGGTCTGCTGAGACGGCAGGCCTGC
AGTGAACCC------ATCCGATCTCACCTGCCCGCGACCCGCGGGCAGCTCGATCCACCCGAGA 
 
 
GGAATCATCATGTCCGACACGCTCGCGTCCGCTGCCGCGGTCCTTCAGAAGTTCTCCCTGGACA
CCTTCGACGGCCTGGAGTGGGAGGTGATGGGTGTCGCGGAAGGCGGCCGAGGGGCTGCTCGCCC
AGGTGCGCGACGCGGTCGACAGGGGTGCGACCCTGCACGTCGGTGGAGAGCTCGCCGAGCACGG
ATGGTTCACCCCGGCAGTCCTGACCGGGGTCACCCCGGACATGCGCGCTTACCGTGAGGAGCTG
TTCGGCCCGGTCGCCGTCGTCTATTCGGTGTCCGACGACGACGAGGCGGTCGCTCTCGCGAACG
ACGTCCCGTTCGGGCTCGGGGGTGCTGTCTTCTCGAGCGACGAGCAGCGGGCGATCGCGGTCGC
GTCGCGACTCGAGGTGGGTATGGCCAATGTGAACACCTCGGCCGGCGAAGGCGCCGACGTGCCG
TTCGGCGGAACCAAGCGTTCCGGCTTCGGGCGGGAACTCGGACCGCTCGGCATCGGCGAATTCG
TCAACCGGCGCGTCTTCTACGTGCAGCGGTGACCTTCCCGCGGGCCCGCGCGTCGACGCAGCGG
GGTCTGCGCCCGCTCGCCGCACGACGGTGACCGGTCGGCGCGCGGCCCGCGGAACAGGTGTCGT
GTCGATCGTCACATGACTAACCTCTAACCGGGACACGGCACATCCGATGATGTGCCGCCCGAGG
ACGACGGCGTCAGGGCGAAGGGCGGATCAGCGATGGGACGATACGACGAGGCGTTCACACGGGC
GACCGAGGACCGTGAGGGTTTCTGGCTCGACGCGGCGTCCGCGATCGACTGGACGGTCACTCCG
ACGCGGGCGCTCGACGACTCCGCCGCCCCGTTCTACCGGTG 
 
 
 
 
xplA (ORF 32) was deleted Stop codon of xplB (ORF 31)  
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d) xplB knockout 
GCGCGACGATCGAGGAGTTCGACGCCTGGTGCCGAGAAGCCGTGCGTCCGCCCACATTCGGCCG
GATCGCTCTCGATGCGCTGGTCGCCGGAGCGGGGCTGACGCCCAAGCAGATCCTGACGCGCACC
GAACCCGAACTGGCACACGAGACTCTGCACTGTGCTGCCCTGGGGATCGACGTCCCGCCGGGAA
AGTGCATCGGCTTCACCGACATCGACGAGATCCGCACGGAAGAGGGCCCGGTCTTCGTCTTCCG
GATGTCCGGCCGGCTGTACGGCCCCGACGACAGCGATGTCAACGAATGGACGATCCACGGCGAA
CCCGATCTGGTGATGTCCAACGGCACCCCGCCGACGATGGCCACCACCTGCACCCAATTGGTGA
ACCGTATCCCCGACGTGC------CCCGAGATGGAGTGTGGAGAATCATGACCGACGTAACTG 
 
 
TCCTGTTCGGAACCGAGACCGGCAACGCCGAGATGGTCGCCGACGACATCGCTTCTGCCCTGGG
GGAATTCGATATCGAGGCCACCGTGGTGGGGATGGAGGACTTCGACGTCGCAGATCTGGCCGCC
TCCGGCACGGTCGTGCTCGTCACCTCCACCTACGGAGAGGGTGAACTGCCGGCGACGACCCAGC
CCTTCTTCGATGCGATGAAGGCGGCCGAGCCTGACCTCACGGGTCTGCGGTTCGGGGCCTTCGG
CCTCGGCGACAGCACCTACGACACCTACAACAACGCGATCGACATCCTCGTCGGTGCGGTGACA
GACGCAGGAGCGACACAGGTCGGCGCAACGGGCCGGCACGATGCCGCGTCCTTCCAGCCGGCGG
ACGGACCCGTGGCCGAGTGGGCCAAACAGTTCGCCGAAGCCCTCTCTGATCGAACTCGACGAGG
AGGACATGAGATGACCGCTGCGTCCATCGATCGCGAGCTCGTGCCGTGGTCGGATCCCGAATTC
AGGAACAACCCCTATCCCTGGTATAGGCGACTGCAACAGGACCATCCGGTGCACAAGCTGGAGG
ACGGCACCTACCTGGTGTCCCGGTACGCCGACGTGAGTCATTTCGCGAAACTGCCCATCATGAG
CGTCGAACCCGGATGGGCCGACGCCGGGCCCTGGGCGGTCGCGAGCGACAC 
 
 
 
 
 
 
 
xplB (ORF 31) was deleted Start codon of xplA (ORF 32)  
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